rfhg_124181.1

Basic information about the TSS

---

TSS ID: rfhg_124181.1 Species: human Chr: chr10		Start: 28532495 End: 28532495 Strand: +
Source datasets	EPD
Protocol	TSS_database
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2328216,EH38E1457613)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000428935.6:-2 ENST00000680735.1:-2 ENST00000375664.8:-2 GeneID: 51322 HGNC/MGI_ID: HGNC:17327 UniProt_ID: Q9BTA9 Q9P1G8 Nearer transcript ids and distances: ENST00000651598.1:273 ENST00000628285.3:276 AK055852:276 ENST00000526722.1:278 AK225846:280 ENST00000528491.5:281 ENST00000681112.1:281 ENST00000679570.1:284 NM_100264.3:284 ENST00000375646.5:289 BC001026:301 view more...

Gene_name: WW domain containing adaptor with coiled-coil Gene_symbol: WAC Gene_synonyms: BM-016 FLJ31290 MGC10753 PRO1741 Wwp4 Gene_source: HGNC:17327

TATA-Box annotation

---

Distance to TSS:	-141
Nearest PromoterID:	NR_033805
Entrez ID:	220906
Nearest Unigene:	Hs.403253
Nearest Refseq:	NR_033805
Nearest Ensembl:
Gene Name:	WW domain containing adaptor with coiled-coil
Gene Alias:	-
Gene Type:	ncRNA
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@WAC p2@WAC p4@WAC p5@WAC p6@WAC p7@WAC p8@WAC p10@WAC
Sample		p1@WAC	p2@WAC	p4@WAC	p5@WAC	p6@WAC	p7@WAC	p8@WAC	p10@WAC
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.40	23.96	2.34	4.87	0.39	5.26	1.17	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	21.85	16.39	4.25	3.03	0.40	6.88	1.21	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	20.06	20.06	2.51	2.70	0.19	6.37	1.54	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	16.22	13.93	2.70	2.49	0.62	4.57	0.62	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	19.80	16.65	1.80	2.47	0.45	3.60	0.45	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	16.47	17.25	1.55	3.49	0.19	4.65	0.58	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	15.25	22.66	1.96	3.92	1.09	3.70	0.87	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	16.96	17.20	0.97	2.42	0.97	2.91	2.18	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	18.38	16.88	1.07	2.14	0.85	2.99	1.07	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	39.41	37.10	2.90	3.48	0.00	9.85	4.64	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	30.32	19.40	3.23	3.23	0.40	8.89	2.02	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	32.12	27.65	4.88	3.25	0.41	9.76	3.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.31	5.00	0.48	0.64	0.32	0.00	0.97	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	14.43	5.71	0.75	1.80	0.45	0.30	0.45	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	11.86	6.81	0.00	1.76	0.44	0.44	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	11.57	5.53	0.00	2.77	0.00	0.00	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	10.05	3.93	0.66	1.75	0.00	0.44	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	12.65	5.91	0.42	1.69	0.42	0.00	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.86	5.33	0.00	1.60	0.00	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	14.89	4.51	0.60	1.20	0.30	0.15	0.30	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	15.64	4.41	0.80	1.74	0.67	0.27	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	15.36	4.83	0.86	1.90	0.69	0.69	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.31	5.43	0.65	2.59	0.39	0.00	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	10.92	6.79	0.24	1.46	0.00	0.24	0.49	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	10.58	7.22	1.55	2.32	0.77	0.26	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.76	7.28	0.95	1.58	0.63	0.95	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	13.74	10.44	1.65	1.65	0.00	0.00	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	12.73	8.49	0.24	3.77	0.24	0.71	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	11.95	6.46	0.97	0.65	0.48	0.16	0.65	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.12	7.78	1.27	1.27	0.90	0.72	0.54	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	7.96	6.70	1.05	3.14	0.84	0.63	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.57	5.47	1.17	1.56	0.20	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.40	8.86	0.84	2.11	0.00	0.63	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.91	8.25	0.82	1.15	0.00	0.33	0.82	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	10.85	4.86	0.37	1.87	0.93	0.75	0.37	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	10.54	6.71	0.77	0.96	0.00	1.34	0.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	13.90	6.74	0.20	1.64	0.00	0.20	0.00	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	10.07	6.04	0.40	1.01	0.00	0.60	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	9.45	9.45	0.81	1.08	0.54	0.27	0.54	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10.56	10.32	0.24	1.92	0.24	0.24	0.24	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.47	5.65	0.47	1.18	0.47	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	10.25	7.91	0.15	1.17	0.73	0.00	0.15	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.96	8.86	0.63	1.27	0.00	0.63	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	11.71	8.39	1.05	1.05	0.17	0.87	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	10.04	8.23	0.80	1.81	1.00	0.20	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	10.93	10.93	0.47	5.12	0.23	0.23	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	8.88	10.08	0.72	0.72	0.24	0.48	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.94	6.86	0.30	0.60	0.30	0.30	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.81	9.10	0.24	0.24	0.24	0.24	0.24	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	13.14	7.08	0.20	1.01	0.40	0.61	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.89	10.66	0.20	2.46	0.82	0.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	6.45	11.34	1.56	1.78	0.00	0.22	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	69.96	0.00	111.94	13.99	13.99	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	6.39	8.52	0.35	0.35	1.06	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.62	6.63	1.33	0.66	0.66	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	22.65	23.49	1.68	10.07	2.52	0.84	0.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	19.29	10.10	1.84	1.84	0.92	0.92	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.81	10.05	0.00	0.97	0.32	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	2.89	4.50	0.64	0.96	0.32	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	15.40	11.94	0.00	4.40	0.63	0.00	0.31	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.76	5.64	1.41	0.71	0.71	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.85	7.85	0.56	1.12	0.56	0.00	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	34.23	11.15	1.59	3.18	1.59	0.00	0.00	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	15.63	7.47	0.68	1.36	0.00	0.00	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	5.52	8.77	0.00	1.30	0.65	0.32	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	4.97	6.03	0.71	3.19	0.00	0.00	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	64.66	0.00	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	31.59	0.00	0.00	7.90	0.00	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.29	4.88	0.49	0.98	0.98	0.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	7.44	6.45	0.50	0.99	0.50	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.32	7.51	0.00	1.88	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.58	4.31	0.00	1.99	0.33	0.33	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	7.73	4.33	0.31	1.24	0.31	0.00	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	9.17	7.64	0.00	0.31	0.31	0.00	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	15.84	3.96	1.90	0.79	0.48	0.79	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	13.96	5.61	1.44	0.80	1.12	0.64	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	16.67	7.89	2.04	0.25	1.15	1.53	0.64	0.13
Adipocyte - omental, donor2	11474-119C7	14.95	2.99	0.00	0.00	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	19.76	4.69	2.34	0.33	0.33	0.67	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	14.67	4.47	0.00	0.00	0.00	1.91	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	2.20	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	8.58	1.81	0.45	0.90	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	10.25	2.26	0.35	0.17	0.00	0.00	0.35	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	24.64	11.34	1.56	0.59	1.37	0.78	0.59	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	24.45	10.55	1.03	0.51	1.03	0.51	0.00	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	21.74	10.04	1.12	0.84	0.28	1.12	0.00	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	28.21	17.63	0.59	0.59	0.59	1.76	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	23.73	15.36	0.88	0.48	0.97	0.72	0.97	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	25.50	8.71	0.65	0.00	0.65	1.61	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	16.53	10.13	0.53	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	19.48	12.24	1.11	0.56	1.67	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.07	10.40	0.42	0.00	0.42	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	14.82	9.80	0.25	1.00	0.75	0.25	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	9.82	6.87	0.33	0.98	0.98	0.33	1.31	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	12.79	7.61	1.52	0.61	0.00	0.00	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	7.07	0.88	0.00	0.00	0.00	0.22	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	4.66	2.15	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	10.25	1.26	0.00	0.00	0.72	0.00	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	0.00	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8.01	2.05	0.21	0.41	0.62	0.00	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	18.88	7.67	0.92	0.69	0.34	0.46	0.92	0.00
Anulus Pulposus Cell, donor2	11463-119B5	16.90	5.88	0.24	0.00	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.03	6.74	0.45	0.45	0.90	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	13.46	4.78	1.30	0.87	0.43	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	0.00	10.70	0.00	4.28	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	9.86	5.38	0.30	0.60	0.60	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	10.12	7.59	0.00	1.26	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.28	5.28	0.00	0.66	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	10.40	5.52	0.65	0.97	0.00	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.19	5.34	0.49	0.00	0.49	0.00	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.13	4.16	1.19	1.19	0.59	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	10.92	8.66	1.88	1.51	1.51	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	9.43	8.71	0.00	1.45	0.00	1.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	3.76	0.00	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.90	5.11	0.99	0.33	0.99	0.16	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	4.09	1.36	1.36	1.36	1.36	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.73	3.32	0.45	0.15	0.15	0.30	0.45	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	9.64	6.97	1.61	1.07	0.54	0.00	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	7.94	4.53	1.89	0.38	0.38	0.00	0.19	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.61	7.22	0.00	0.00	0.27	0.27	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	1.95	3.90	0.00	2.93	0.00	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.29	4.64	1.00	0.50	0.17	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	0.00	0.00	1.20	0.00	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	10.62	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.09	7.89	1.37	0.51	0.51	0.17	0.69	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	12.58	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	12.62	9.22	0.49	1.46	0.49	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	8.35	6.45	1.14	0.38	1.14	0.76	1.52	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	3.63	2.42	2.42	1.21	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.68	8.55	1.14	0.57	1.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	7.70	6.20	0.86	0.43	0.21	0.21	0.00	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	7.48	2.84	0.52	0.26	0.77	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.98	7.51	0.47	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.36	6.11	0.64	1.29	1.29	0.32	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.85	3.57	0.00	0.71	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.70	4.68	0.00	0.00	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	5.72	3.91	0.90	1.20	0.90	0.30	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	3.56	0.00	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	7.12	5.09	1.02	0.00	0.51	0.00	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	9.93	4.58	0.51	2.04	1.53	0.25	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.99	2.54	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.90	6.04	0.86	1.29	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	8.47	5.72	0.42	0.42	0.21	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.25	4.35	0.58	0.58	0.29	0.00	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	10.39	6.61	1.89	1.89	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.80	5.26	0.17	0.34	0.34	0.00	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	2.32	0.00	6.95	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	6.34	2.11	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.22	3.65	0.86	0.21	0.64	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.01	4.81	1.20	0.00	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	7.29	5.83	0.00	0.00	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	10.34	7.82	0.69	0.92	0.69	0.00	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	10.20	0.00	10.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.85	3.31	0.76	0.76	0.25	0.51	0.76	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	5.57	5.78	1.03	0.83	0.62	0.41	0.62	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	9.18	4.28	0.61	0.92	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	12.43	9.08	0.48	2.39	0.96	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.76	5.10	0.67	0.22	0.44	0.00	0.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	3.05	0.00	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	7.20	9.97	0.00	0.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.65	7.41	1.06	1.32	0.53	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.27	4.36	0.36	0.36	0.36	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	9.46	2.70	0.12	0.12	0.37	0.00	0.37	0.00
Astrocyte - cerebellum, donor2	11580-120F5	8.56	2.74	0.34	0.00	0.34	0.17	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	3.78	1.68	0.00	0.00	0.00	0.21	0.63	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	28.93	12.20	1.39	0.70	0.35	0.70	0.70	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	27.50	9.54	1.13	0.81	0.81	0.49	0.97	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	27.89	9.99	1.34	1.34	0.15	0.45	1.04	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	32.23	17.89	1.72	3.21	1.26	0.57	0.46	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	37.21	19.17	1.75	2.76	0.88	0.75	0.88	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	36.76	19.69	2.05	1.93	2.05	0.11	0.91	0.46
Basophils, donor1	12241-129G9	48.38	17.00	0.78	0.26	0.52	1.31	0.00	0.78
Basophils, donor2	12242-129H1	62.06	42.93	3.97	0.00	2.16	1.08	0.00	3.25
Basophils, donor3	12243-129H2	39.40	32.05	2.06	0.44	0.88	0.88	0.15	2.20
Bronchial Epithelial Cell, donor1	11511-119G8	4.53	0.43	0.00	0.00	0.22	0.00	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	0.46	0.46	0.00	0.00	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.06	1.88	1.88	0.00	0.00	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	8.32	1.04	0.62	0.00	0.21	0.42	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	9.90	2.53	0.00	0.00	0.00	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	19.97	3.78	0.18	1.44	0.54	0.36	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	27.93	11.95	1.75	2.68	0.93	1.03	0.31	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	43.32	14.67	2.56	2.10	1.40	0.47	0.00	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	31.98	25.58	0.96	1.28	0.96	0.32	0.64	5.76
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	10.34	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	51.85	37.76	0.00	0.00	0.56	0.56	0.56	3.94
CD14+ Monocytes, donor2	11305-117B9	51.04	59.95	3.53	1.30	0.74	1.86	0.19	6.87
CD14+ Monocytes, donor3	11381-118B4	48.08	53.13	3.29	1.76	1.10	0.44	0.44	6.59
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	42.17	24.34	2.26	0.57	0.00	2.26	0.28	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	37.91	23.50	1.90	1.52	1.14	1.52	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	46.02	25.97	0.66	1.64	0.66	1.64	0.33	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	38.45	32.52	2.60	2.46	1.16	4.19	0.43	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	41.04	26.25	2.72	2.41	1.51	5.13	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	53.06	37.19	2.13	1.18	1.90	2.61	0.24	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	33.65	28.29	0.84	2.51	1.34	2.51	0.17	1.51
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	35.61	23.74	1.38	2.76	1.10	3.59	1.38	1.93
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	44.63	33.22	1.49	2.48	0.99	1.74	0.99	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	23.50	22.91	1.37	1.96	0.39	1.17	0.39	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	29.91	27.42	1.42	2.31	1.25	1.78	0.71	1.42
CD14+ monocytes - treated with BCG, donor3	11880-125C8	35.69	30.25	0.87	1.31	0.87	1.52	0.65	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	30.20	30.90	1.40	1.40	1.17	2.81	0.23	2.11
CD14+ monocytes - treated with Candida, donor2	11878-125C6	50.69	52.80	4.75	1.58	1.58	2.64	0.53	2.64
CD14+ monocytes - treated with Candida, donor3	11888-125D7	34.39	37.72	2.22	1.11	0.00	2.22	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	32.28	32.28	1.64	3.72	0.74	2.38	0.59	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	36.12	23.75	2.00	2.20	0.80	2.99	0.00	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	41.22	27.07	1.67	1.25	2.71	2.08	1.04	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	27.91	30.66	1.14	5.26	1.14	1.14	0.46	2.06
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	39.13	29.86	1.58	1.58	1.36	1.58	0.68	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	36.66	29.68	3.06	1.31	0.87	0.87	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	36.04	27.44	2.15	1.61	1.88	2.42	0.00	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	33.32	32.45	2.09	2.09	0.70	1.92	1.57	1.74
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	40.40	41.24	2.52	1.26	2.10	3.37	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	26.45	29.21	0.92	3.31	0.92	0.73	0.55	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	42.98	29.59	2.11	1.41	0.35	2.47	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	42.56	44.31	0.44	2.19	0.44	2.19	1.32	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	31.21	22.84	1.22	1.92	0.52	1.92	0.70	1.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	34.57	29.73	0.37	2.60	0.74	0.37	0.00	2.60
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	38.15	25.65	0.43	2.16	1.72	0.43	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	28.25	28.25	1.23	1.64	1.23	2.05	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	35.00	34.07	1.39	0.93	0.70	1.62	0.23	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	29.23	40.60	0.70	1.86	0.46	1.16	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	30.51	17.00	0.65	2.62	1.53	1.09	0.22	3.05
CD14+CD16+ Monocytes, donor2	11801-124D1	42.27	21.71	1.15	0.46	0.92	0.92	0.23	3.70
CD14+CD16+ Monocytes, donor3	11912-125G4	33.79	21.44	1.30	0.65	1.08	0.65	0.22	3.47
CD14+CD16- Monocytes, donor1	11788-124B6	41.27	36.75	1.09	2.02	1.71	1.25	0.31	2.65
CD14+CD16- Monocytes, donor2	11799-124C8	30.21	34.23	1.57	1.22	0.87	0.35	0.35	2.10
CD14+CD16- Monocytes, donor3	11910-125G2	66.67	59.53	1.56	3.57	1.11	1.34	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	45.42	20.41	2.81	1.02	1.28	1.28	0.77	5.61
CD14-CD16+ Monocytes, donor2	11800-124C9	45.01	19.76	1.98	1.54	0.88	1.98	0.44	6.59
CD14-CD16+ Monocytes, donor3	11911-125G3	40.64	17.69	1.47	0.63	0.84	1.47	0.42	5.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	32.52	36.58	0.00	0.00	2.03	4.06	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	42.71	48.81	2.03	0.00	4.07	1.36	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	59.03	50.74	1.04	1.04	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	55.44	52.24	0.53	2.67	0.00	1.07	0.00	10.66
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	48.25	72.37	0.00	0.54	1.07	0.54	0.00	2.68
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	49.84	41.41	0.00	0.00	0.00	0.00	0.00	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	59.61	46.28	0.00	0.00	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	51.41	50.09	0.00	0.00	2.64	0.00	3.95	5.27
CD19+ B Cells, donor1	11544-120B5	55.89	82.19	0.00	5.75	2.47	0.00	0.00	15.62
CD19+ B Cells, donor2	11624-122B4	52.96	89.95	2.90	8.71	0.00	0.00	0.00	7.98
CD19+ B Cells, donor3	11705-123B4	45.94	107.02	4.04	6.06	2.02	0.50	1.01	9.09
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	89.30	12.53	3.23	2.83	3.64	2.42	2.42	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	64.72	7.59	1.60	0.80	3.20	1.60	2.40	2.80
CD34+ Progenitors, donor1	11545-120B6	28.11	29.12	3.01	1.00	0.00	0.00	0.00	3.01
CD34+ Progenitors, donor2	11625-122B5	39.89	47.75	2.81	0.00	0.56	2.81	1.69	2.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	33.07	19.92	3.38	1.50	0.00	0.38	0.75	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	32.70	16.91	0.90	0.90	0.68	0.45	0.90	1.35
CD4+ T Cells, donor1	11225-116C1	99.98	53.56	5.71	1.79	2.50	2.14	2.14	8.21
CD4+ T Cells, donor2	11306-117C1	72.26	49.60	5.51	5.51	1.84	1.84	1.84	12.86
CD4+ T Cells, donor3	11382-118B5	65.57	39.65	5.79	3.96	2.74	1.52	0.61	7.93
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	33.18	29.86	1.28	1.79	0.77	0.77	0.51	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	30.55	20.44	1.12	1.12	1.12	0.22	0.00	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	38.52	23.28	1.15	1.15	0.86	0.29	0.00	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	58.31	45.51	3.79	1.42	0.95	0.47	0.95	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	66.72	37.93	3.51	0.00	2.11	0.00	0.00	8.43
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	26.37	0.00	6.59	0.00	0.00	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	32.08	21.68	3.03	1.30	0.87	0.72	0.58	1.01
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	28.64	16.61	1.19	1.36	0.68	1.86	0.00	1.69
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	25.47	15.15	1.45	1.93	1.13	1.29	0.16	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	43.93	34.07	2.69	3.59	0.00	0.90	0.90	6.28
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	38.43	30.40	2.80	1.05	2.10	0.70	0.35	5.24
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	64.24	25.08	3.08	1.32	2.20	1.76	0.00	3.52
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	36.26	37.95	2.11	1.26	0.84	0.84	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	24.31	20.57	0.62	1.66	2.29	0.42	0.00	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	21.72	21.38	0.33	2.00	0.67	1.34	0.00	2.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	50.04	37.26	1.90	1.90	1.09	2.18	0.54	2.99
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	58.42	41.80	2.68	1.07	0.00	1.07	0.00	3.22
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	69.94	44.83	0.00	0.00	0.00	1.79	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	38.94	25.59	1.30	1.11	1.30	2.23	0.19	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	30.54	18.41	1.95	0.22	0.65	0.65	0.43	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	32.78	24.59	1.26	0.63	1.26	0.84	0.42	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	46.52	29.83	3.54	2.53	0.00	0.51	0.00	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	37.69	30.76	0.43	0.43	0.87	0.87	0.00	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	49.68	39.66	1.74	1.74	3.05	1.74	1.31	3.05
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	72.25	53.45	2.47	1.98	0.49	0.99	0.49	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	66.47	34.16	1.85	1.85	0.00	2.77	1.85	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	57.23	40.48	0.00	2.79	0.00	1.40	1.40	8.37
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	78.37	57.32	1.94	0.00	2.49	3.05	0.83	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	83.43	59.88	2.70	0.49	1.47	1.47	0.49	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	73.92	38.50	1.54	0.00	1.54	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	69.83	43.69	2.86	1.79	1.07	1.79	1.79	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	69.25	52.63	4.15	2.77	1.38	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	70.72	52.06	4.91	3.60	0.65	2.62	0.33	4.91
CD8+ T Cells, donor2	11307-117C2	69.83	58.57	9.39	4.13	1.50	2.63	1.13	10.14
CD8+ T Cells, donor3	11383-118B6	75.49	54.03	6.82	2.27	1.51	3.79	1.26	15.40
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	9.18	9.41	1.61	1.15	0.23	1.15	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	7.67	6.95	0.96	2.40	0.48	0.72	0.72	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	6.29	9.30	1.37	1.92	0.27	0.82	1.09	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	7.81	16.21	0.90	2.10	0.30	1.20	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	8.88	12.48	0.72	0.48	0.48	1.44	0.72	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.46	9.32	0.91	1.14	0.23	0.68	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	11.95	8.26	3.48	1.30	0.22	2.17	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	12.63	5.53	2.37	2.37	0.26	1.84	0.79	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11.73	7.97	3.52	1.17	0.23	2.35	0.23	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	7.85	7.55	0.91	0.60	0.00	3.02	0.00	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	8.72	9.88	2.61	2.32	0.29	1.45	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	13.06	11.46	2.13	1.33	0.00	1.87	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.07	12.26	1.31	0.44	0.88	3.50	0.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	23.23	10.47	2.28	0.91	0.46	5.47	1.82	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	12.68	8.95	1.49	2.24	0.00	3.73	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	10.08	11.16	1.44	0.72	0.36	2.16	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	13.52	8.06	0.86	0.58	0.58	1.44	0.86	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	10.61	9.90	1.65	0.94	0.24	1.65	0.71	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	15.53	10.77	2.22	1.27	0.63	5.07	1.58	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	13.84	9.53	0.92	1.54	0.00	1.23	0.92	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	13.46	11.86	2.24	0.96	0.00	1.92	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	15.68	8.03	3.44	1.15	0.38	2.29	1.53	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	16.55	10.25	1.58	0.79	0.39	3.15	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	5.29	3.03	1.51	0.00	1.51	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	44.97	10.44	5.62	2.41	0.00	12.04	0.00	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	39.87	11.19	6.29	2.80	0.00	11.89	3.50	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	49.09	14.02	6.01	5.01	1.00	12.02	3.01	2.00
Cardiac Myocyte, donor1	11525-119I4	82.25	20.11	0.00	0.00	0.00	0.00	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	15.81	7.41	0.49	0.99	0.00	0.49	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	10.73	4.63	0.42	0.53	0.42	0.21	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	15.60	4.51	2.08	0.00	1.04	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	12.08	3.91	0.00	0.00	0.00	0.71	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	16.38	5.58	1.48	1.37	0.11	0.68	0.57	0.46
Chondrocyte - re diff, donor2	11339-117F7	13.43	10.74	0.00	0.90	0.00	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	20.62	6.47	0.81	0.81	0.81	1.21	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	25.02	13.77	1.15	1.95	0.34	0.46	1.03	1.15
Ciliary Epithelial Cells, donor2	11323-117D9	19.24	8.76	0.64	1.07	0.86	0.21	0.21	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	18.67	10.53	0.53	0.88	0.27	0.27	0.80	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	49.15	13.85	1.10	1.10	2.02	0.37	1.19	0.92
Corneal Epithelial Cells, donor1	11526-119I5	5.49	0.66	0.66	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	5.69	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	7.41	0.77	0.51	0.26	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	31.20	6.93	1.16	0.66	0.99	1.98	1.32	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	26.49	7.89	0.95	0.00	0.63	1.58	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	3.45	0.00	3.45	0.00	0.00	0.00	6.90
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	15.87	4.86	0.97	0.76	0.32	1.19	0.11	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	72.77	39.29	2.39	2.05	0.68	1.02	0.00	6.83
Dendritic Cells - plasmacytoid, donor2	11309-117C4	46.35	43.09	2.61	0.65	1.31	0.00	0.65	3.92
Dendritic Cells - plasmacytoid, donor3	11385-118B8	69.69	48.88	0.97	0.00	0.48	2.90	0.00	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	15.51	4.50	0.67	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	11.15	2.35	0.59	0.00	0.59	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	10.75	3.68	0.00	0.57	0.57	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	15.73	3.54	0.79	1.18	0.00	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	8.44	4.94	0.29	0.29	0.87	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	12.00	7.53	2.59	0.94	0.47	0.47	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	9.99	4.38	0.88	0.70	0.88	0.00	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	19.28	7.76	0.66	1.11	2.22	0.44	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	15.52	7.30	0.30	0.30	0.91	0.00	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	23.68	11.28	0.56	1.41	0.85	0.56	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	7.73	6.54	0.89	0.00	0.30	0.30	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	10.93	3.12	0.52	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	9.36	6.38	0.71	0.57	0.00	0.14	0.43	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	22.01	6.40	0.80	0.80	0.00	1.60	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	13.10	5.24	0.00	1.05	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	30.19	14.91	1.49	1.74	0.87	0.50	1.62	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	25.42	9.78	1.09	0.22	0.87	0.00	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	30.17	11.24	1.22	0.24	0.24	0.37	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	11.38	4.55	0.00	0.00	2.28	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	15.37	2.79	0.70	0.00	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	17.90	5.18	0.79	0.31	0.31	0.63	0.16	0.00
Eosinophils, donor1	12244-129H3	106.73	30.49	0.00	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	462.07	130.37	28.05	6.60	11.55	1.65	0.00	3.30
Eosinophils, donor3	12246-129H5	285.35	103.44	7.13	7.13	7.13	3.57	3.57	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	4.89	1.22	0.49	0.49	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	4.16	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	22.99	5.34	1.23	0.82	0.82	0.82	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.05	1.97	0.99	0.66	0.33	0.44	0.33	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	5.85	2.82	0.54	1.63	0.33	0.43	0.33	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	15.89	8.00	0.61	0.97	0.24	0.49	1.09	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	14.47	4.09	0.68	0.27	1.50	0.55	0.55	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	13.92	5.80	1.48	0.84	0.63	0.84	0.63	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	22.13	4.48	1.58	1.05	0.53	1.32	1.58	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	13.95	5.98	2.66	1.66	1.33	0.66	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	10.43	5.90	0.45	0.00	0.45	0.00	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.16	5.31	1.52	0.00	0.00	1.52	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	11.83	4.42	1.10	0.63	0.32	0.16	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	24.25	9.70	1.82	0.30	0.61	0.30	1.52	0.00
Fibroblast - Cardiac, donor5	11456-119A7	19.42	11.55	1.02	0.38	0.25	0.51	0.76	0.13
Fibroblast - Cardiac, donor6	11460-119B2	17.58	6.37	1.52	0.61	0.45	0.30	0.76	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.00	4.56	0.40	0.13	0.00	0.27	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	24.59	11.65	1.29	1.29	0.00	0.86	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	17.58	5.86	0.00	2.93	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	13.84	2.77	0.92	0.00	0.00	0.23	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	26.46	11.87	0.51	1.87	0.68	0.51	1.87	0.17
Fibroblast - Dermal, donor1	11269-116G9	9.63	4.46	0.47	0.94	0.23	0.23	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	15.57	2.36	0.00	0.00	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	10.88	4.96	0.48	0.36	0.48	0.60	0.24	0.12
Fibroblast - Dermal, donor4	11450-119A1	21.93	6.44	0.57	0.45	1.24	0.90	0.57	0.00
Fibroblast - Dermal, donor5	11454-119A5	24.07	8.02	1.22	0.00	0.35	0.00	0.52	0.00
Fibroblast - Dermal, donor6	11458-119A9	23.23	6.33	1.14	0.65	0.65	0.49	0.49	0.16
Fibroblast - Gingival, donor1	11237-116D4	18.12	5.00	1.04	0.21	0.83	0.42	0.62	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	20.70	9.43	2.62	1.05	1.83	1.31	0.52	0.52
Fibroblast - Gingival, donor2	11318-117D4	23.06	6.85	0.53	0.92	0.53	0.26	0.26	0.53
Fibroblast - Gingival, donor3	11394-118C8	30.94	11.02	1.26	0.87	0.58	0.68	0.48	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	29.09	8.31	3.12	1.04	0.00	0.00	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	19.21	4.93	1.23	0.88	1.41	0.35	0.88	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	17.30	8.11	2.18	0.78	0.31	0.78	0.47	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.71	6.36	1.76	0.81	0.81	1.08	0.54	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.76	5.29	3.53	0.00	1.06	1.41	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	16.53	7.60	1.61	0.73	0.73	0.58	0.88	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	19.91	11.73	0.55	0.27	0.82	1.36	0.55	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	18.54	8.23	2.85	0.66	1.10	0.99	0.77	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	22.30	8.80	2.49	0.73	0.29	1.47	1.03	0.29
Fibroblast - Lung, donor1	11270-116H1	8.16	1.36	0.00	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	34.32	5.97	0.00	0.00	1.49	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	18.57	6.33	0.63	1.06	0.63	0.21	0.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	2.50	0.00	0.00	0.83	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.64	0.56	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	10.56	3.25	0.00	0.00	0.41	0.00	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	23.28	3.30	0.19	0.39	1.36	0.19	0.58	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	26.24	8.19	1.21	1.67	0.76	0.76	0.61	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	24.78	7.65	0.61	0.61	1.53	0.61	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	22.90	3.43	0.76	0.00	0.76	1.14	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	12.69	7.02	1.35	0.54	0.54	1.35	0.54	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	24.12	6.15	1.28	0.35	0.58	0.70	0.35	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	12.93	4.31	0.55	0.66	0.44	0.11	0.55	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	8.13	2.84	0.61	0.00	0.81	0.41	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.69	2.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	9.49	4.74	0.79	0.40	0.00	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	27.19	5.75	2.18	0.20	0.20	1.39	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	19.72	6.57	0.18	2.13	1.24	0.00	0.71	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	16.56	6.50	1.18	1.58	0.79	0.39	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	19.25	2.41	0.90	0.30	0.30	0.90	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	25.80	7.23	1.19	0.22	1.73	0.86	0.65	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	25.81	2.78	2.78	0.25	1.52	1.52	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	12.63	3.45	1.31	1.48	0.49	1.15	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.65	3.61	1.40	0.40	1.20	0.40	0.20	0.60
Fibroblast - skin normal, donor2	11561-120D4	21.90	6.23	1.21	0.40	1.91	0.80	0.50	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	32.64	8.46	2.42	0.30	0.30	0.30	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	22.29	5.96	1.08	0.91	0.58	0.50	0.33	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	27.86	9.40	1.37	0.34	2.56	0.51	0.68	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.33	6.24	1.64	0.00	0.33	0.66	1.97	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	22.69	7.56	1.81	0.32	1.07	0.32	1.28	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	17.04	3.54	0.84	1.01	1.35	0.17	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.70	4.08	0.63	2.35	0.94	0.16	0.47	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	22.16	44.32	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	38.35	8.72	4.36	0.87	0.87	3.49	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	14.39	4.51	1.73	0.17	0.35	0.52	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	13.27	4.94	1.30	2.08	0.26	0.78	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	15.84	5.11	2.30	0.51	0.26	0.51	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	26.03	9.19	0.77	0.77	0.00	3.83	0.00	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	33.18	8.29	0.64	2.55	0.64	1.91	0.64	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	72.74	9.41	1.14	2.28	2.28	1.43	1.43	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	69.77	13.79	4.96	2.76	2.21	3.58	1.65	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	41.10	6.62	2.28	2.05	0.00	1.60	1.14	2.74
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	48.74	4.56	1.39	1.59	1.59	1.19	0.99	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	44.14	10.31	3.17	1.59	1.32	3.44	1.59	3.44
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	39.79	4.89	2.94	0.33	2.61	3.59	0.33	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	54.39	3.54	1.33	1.77	1.33	0.88	0.00	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	37.87	16.96	0.57	0.99	1.13	0.85	0.85	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	36.08	9.48	0.86	1.23	0.99	0.74	1.11	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	27.67	8.60	0.27	1.61	0.00	0.81	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	35.68	8.80	0.87	0.87	0.62	1.12	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	33.36	10.52	0.97	0.83	1.52	0.42	0.83	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	21.55	7.12	0.20	0.81	0.00	0.20	0.41	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	24.42	8.44	1.14	0.91	0.46	1.37	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	31.02	8.47	0.62	1.12	1.62	0.37	0.50	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	34.10	7.65	0.66	0.44	0.87	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	26.59	11.52	1.48	1.48	0.00	0.89	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	34.49	11.76	0.95	1.43	0.64	0.95	0.32	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	25.92	6.26	1.34	0.89	1.34	0.00	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	29.44	11.69	1.21	1.21	0.00	0.60	1.21	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	33.59	12.38	0.68	1.36	1.19	0.51	1.19	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	32.28	11.08	0.98	1.15	1.33	0.71	0.35	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	18.83	20.92	1.25	1.46	0.52	0.94	0.62	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.59	16.39	1.20	1.71	0.68	0.51	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	35.96	11.07	0.89	1.22	0.55	0.89	1.33	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	26.79	9.48	0.67	1.25	0.92	1.41	0.67	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	29.61	10.82	1.43	0.20	0.41	0.41	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	28.47	9.49	1.03	0.41	0.83	0.62	0.21	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.24	12.11	1.04	0.92	0.35	0.92	0.69	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	25.85	10.67	0.50	0.83	0.83	0.67	0.33	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	24.47	8.38	0.66	0.88	0.00	1.54	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	27.92	13.90	0.25	1.84	0.98	1.48	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	28.20	9.08	0.97	1.30	0.65	0.65	0.49	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	27.26	15.39	1.60	0.64	0.96	0.32	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	25.96	10.99	0.57	0.95	0.38	0.57	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	21.67	8.07	0.79	0.95	0.00	0.63	0.95	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	20.07	12.16	0.61	2.43	0.00	0.61	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	27.39	10.04	0.73	1.36	0.63	0.52	0.31	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	23.27	7.90	0.00	0.66	0.44	0.66	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	21.32	9.26	1.12	1.40	0.00	1.12	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	17.50	10.93	0.74	1.02	0.28	1.39	0.56	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	15.78	6.42	2.14	2.94	0.27	0.27	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.66	7.19	1.68	0.92	0.31	0.77	0.31	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.47	7.64	0.91	0.52	1.17	0.52	0.65	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	18.70	5.42	0.27	0.81	0.27	0.27	1.36	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	19.91	7.01	1.47	2.21	0.18	1.29	0.55	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	22.15	10.31	0.88	2.63	1.75	1.10	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	24.79	9.92	0.99	0.00	0.99	1.98	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	19.92	8.71	0.40	1.06	0.40	0.53	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	17.35	10.29	0.20	1.61	0.20	0.61	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	32.28	32.79	3.05	2.54	1.52	2.54	3.05	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	62.50	16.92	0.40	0.40	1.00	0.60	1.19	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	49.46	15.41	0.92	1.08	1.08	0.62	0.46	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	61.37	17.39	1.02	1.23	2.45	1.23	1.02	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	16.27	6.57	0.00	0.63	0.31	0.63	0.31	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	11.87	5.37	0.57	0.00	0.00	0.28	0.28	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	41.97	8.76	1.84	0.46	0.00	0.46	0.92	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	42.07	17.32	4.95	4.95	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	38.29	14.70	3.87	3.09	3.09	2.71	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	33.69	24.07	1.60	3.21	1.60	3.21	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	33.04	3.48	0.00	3.48	0.00	1.74	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	30.60	9.44	0.65	3.58	1.30	2.60	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	35.00	7.41	1.24	3.71	0.00	0.41	2.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	13.33	16.66	10.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	29.08	14.54	1.96	2.52	1.12	1.12	1.12	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	28.11	11.11	1.96	2.61	0.65	0.98	1.63	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	32.71	10.90	2.52	11.74	0.00	0.84	0.00	7.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	37.53	10.18	1.59	3.50	1.27	1.91	0.64	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	24.46	7.81	1.70	1.36	0.68	0.68	1.36	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	39.67	6.26	0.00	2.09	0.00	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	44.10	11.45	0.00	1.15	1.15	1.72	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	18.05	4.74	0.30	2.96	1.48	0.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	8.47	0.00	15.25	0.00	3.39	0.00	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	32.31	14.50	1.66	1.66	0.41	1.66	1.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	26.69	12.43	1.61	1.15	1.15	2.07	0.69	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	10.54	5.27	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	28.83	10.38	2.31	1.92	0.77	2.69	0.38	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	20.21	5.87	0.98	1.96	1.30	1.96	1.63	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	16.72	4.68	1.34	1.34	0.00	0.00	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	34.67	9.63	1.93	2.70	1.16	1.16	0.77	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	30.81	21.91	2.74	3.08	0.34	4.11	2.40	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	44.73	4.97	7.45	4.97	0.00	0.00	4.97	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	33.97	10.38	1.89	1.42	1.42	0.47	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	30.17	9.05	0.60	3.62	0.00	1.21	1.21	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	26.96	9.16	2.03	2.03	0.00	1.02	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	33.50	12.36	1.60	3.59	1.60	1.20	0.00	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	41.44	12.33	0.99	5.43	0.99	1.48	1.97	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	47.22	22.43	1.18	2.36	2.36	1.18	1.18	8.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	25.67	7.00	2.92	1.17	0.00	1.17	0.00	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	42.57	11.85	0.44	2.19	0.44	0.88	0.88	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	30.52	5.09	3.39	6.78	0.00	2.54	1.70	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	23.88	8.95	0.60	1.79	1.19	1.19	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	20.87	10.19	1.94	2.91	0.00	1.46	0.97	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	20.54	2.28	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.06	5.82	1.25	1.25	0.00	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	4.50	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.78	6.34	0.00	1.90	0.00	0.00	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	6.68	2.92	0.42	1.25	0.00	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	14.97	6.73	2.20	1.39	0.70	0.93	0.58	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	20.09	8.27	1.35	1.35	0.84	2.03	0.51	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	17.29	5.69	1.59	1.37	0.46	0.91	0.23	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	17.05	6.89	1.64	0.87	0.66	1.86	0.44	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	19.34	7.31	2.79	1.50	0.86	1.07	0.86	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	18.30	6.89	1.72	0.65	0.65	1.29	0.65	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	15.07	5.23	1.99	1.12	0.37	1.74	0.12	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	15.78	4.63	1.72	1.03	0.00	1.54	0.51	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	13.46	2.88	1.28	0.64	0.64	1.60	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	9.51	3.36	0.56	0.00	0.00	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.90	0.87	0.00	0.43	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	10.58	2.64	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.00	1.76	0.00	0.35	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	2.91	0.00	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	9.79	2.80	0.17	1.75	0.17	0.17	0.70	0.00
Hepatocyte, donor1	11523-119I2	25.42	7.26	0.00	1.21	2.42	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	30.17	16.16	3.23	5.39	1.08	0.00	1.08	1.08
Hepatocyte, donor3	11684-122I1	39.88	15.34	1.23	0.61	2.45	1.84	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	64.62	9.79	1.96	0.00	0.00	1.96	0.65	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	45.79	22.02	1.05	2.45	1.22	1.40	1.92	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	14.27	6.04	0.41	0.96	0.69	0.14	0.41	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	0.00	0.00	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	6.68	0.00	0.00	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	0.00	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	2.56	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	4.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	22.74	3.25	3.25	0.00	1.62	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	8.34	6.67	0.00	0.00	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	19.85	5.29	2.65	0.00	0.00	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	5.54	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	15.75	3.15	1.89	0.00	0.00	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	4.64	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.09	4.52	1.29	0.00	0.00	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	17.71	6.44	3.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	18.74	5.70	0.00	0.00	0.81	0.81	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	12.17	2.10	0.84	0.00	0.00	0.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	21.70	0.80	1.61	0.00	0.80	0.80	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	10.16	0.92	0.92	0.00	0.00	2.77	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	13.22	0.94	0.00	0.94	0.47	2.83	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	8.16	1.81	0.00	0.00	0.00	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	19.37	5.38	1.08	0.00	0.00	2.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	1.27	0.00	2.54	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	14.03	2.55	0.64	0.64	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	3.65	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.71	2.86	2.14	0.00	0.00	1.43	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	0.00	3.32	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.35	2.16	0.31	0.31	0.62	0.31	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	3.51	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	3.14	3.14	0.00	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	19.47	1.39	2.09	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	2.21	0.00	0.00	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	0.00	0.00	0.00	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	18.31	0.87	1.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	4.50	2.25	0.00	0.00	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	20.27	5.33	1.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	27.71	2.77	1.39	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	2.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	27.61	3.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	48.41	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	22.20	1.06	0.00	0.00	0.00	1.06	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	11.75	4.24	0.82	0.24	0.41	0.16	0.08	0.00
Keratinocyte - epidermal, donor2	11349-117G8	9.96	3.51	0.00	0.59	0.59	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	19.03	4.54	0.57	1.70	0.28	0.38	0.47	0.19
Keratinocyte - oral, donor1	11251-116E9	30.65	9.19	0.79	1.59	0.79	0.45	0.68	0.11
Keratocytes, donor1	11527-119I6	20.97	2.41	0.00	1.03	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	4.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	26.28	4.15	0.40	0.59	0.40	0.20	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	57.15	8.79	0.00	0.00	2.20	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	14.02	10.79	0.00	0.00	0.00	0.00	1.08	2.16
Lens Epithelial Cells, donor2	11609-120I7	23.18	8.30	0.23	0.69	0.46	0.35	0.46	0.12
Lens Epithelial Cells, donor3	11690-122I7	26.03	7.67	1.61	0.71	0.91	0.40	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.15	6.76	0.83	0.24	0.36	0.12	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.30	3.63	0.00	0.28	0.56	0.00	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	13.54	8.19	0.94	1.10	0.31	0.63	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.99	4.30	0.00	0.54	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.36	1.89	0.00	0.63	0.00	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.44	3.99	0.43	0.54	0.11	0.00	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	13.54	11.49	0.82	0.82	0.00	0.00	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.56	2.53	0.25	0.00	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.46	5.35	0.28	0.42	0.14	0.28	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	12.26	5.14	0.40	1.19	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.98	3.88	0.39	0.00	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.22	1.48	0.19	0.19	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.62	5.23	1.05	0.35	0.35	0.00	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.68	1.43	0.00	0.24	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.49	5.08	0.14	0.27	0.00	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.47	6.16	0.00	1.85	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.74	0.62	0.62	0.00	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.40	3.48	0.37	0.37	0.18	0.00	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	10.86	3.95	0.99	0.99	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.10	0.59	0.29	0.59	0.00	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.23	2.49	0.50	0.00	0.00	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	10.18	4.85	0.00	0.00	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.16	2.96	0.27	0.00	0.27	0.27	0.81	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.87	4.69	0.00	0.61	0.30	0.00	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.78	5.18	0.00	0.52	0.00	1.04	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.47	3.77	0.84	0.42	1.05	0.00	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.66	4.06	0.15	0.60	0.00	0.00	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	14.45	2.75	0.69	0.69	0.00	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.15	1.13	0.56	0.38	0.00	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	6.15	2.97	0.32	0.53	0.11	0.11	0.21	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	12.11	2.42	0.97	1.45	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	9.92	1.65	0.99	0.00	0.33	0.33	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.45	2.35	0.12	0.87	0.12	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	14.07	10.74	1.11	1.48	0.74	0.00	0.74	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.18	2.72	0.00	0.74	0.25	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.67	2.20	0.00	0.27	0.41	0.41	0.27	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	13.51	7.08	0.32	0.32	0.64	0.00	0.64	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.35	4.87	0.30	0.61	0.61	0.30	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	12.18	6.02	0.28	0.28	0.42	0.00	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	13.51	4.62	0.00	0.00	0.00	0.00	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.36	1.45	0.00	0.97	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.45	1.87	0.16	0.31	0.47	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.52	4.30	0.36	1.07	0.72	0.00	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.84	2.29	0.33	0.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.65	1.88	0.00	0.24	0.24	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.36	5.82	0.50	0.62	0.37	0.12	0.25	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.89	1.02	0.26	0.26	0.26	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	7.76	3.28	0.60	0.30	0.00	0.30	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	9.06	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	21.48	5.37	0.77	0.77	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	18.56	5.20	1.48	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	17.77	5.92	1.27	1.69	0.42	0.85	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.18	5.63	0.70	2.11	0.70	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	17.75	3.74	0.00	2.80	0.00	1.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.97	4.12	1.03	2.06	0.52	1.03	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	9.52	2.38	1.19	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13.57	3.17	0.68	0.00	1.13	0.23	0.68	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	22.98	4.65	0.58	2.04	0.29	0.58	0.58	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	27.91	9.00	1.35	4.50	1.35	1.35	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	18.29	6.77	1.63	0.54	0.14	0.68	0.41	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	17.97	5.65	1.54	2.05	0.51	0.51	0.51	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	22.94	3.88	0.71	0.71	0.35	1.41	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	27.32	7.33	0.67	1.33	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	26.49	6.11	1.02	5.60	0.51	2.04	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	23.48	12.01	1.87	0.80	0.53	0.80	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	27.02	8.50	1.70	2.27	0.76	1.51	0.57	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	26.38	7.36	1.23	1.23	0.00	0.61	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	23.65	8.97	0.82	1.63	0.82	1.63	1.63	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	22.70	10.41	1.25	3.75	1.04	0.83	0.42	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	23.82	9.25	0.84	1.68	0.84	0.28	1.12	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	20.61	7.21	0.00	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	30.19	10.16	1.45	3.48	0.29	1.16	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	19.13	7.17	0.60	1.49	1.20	0.60	0.30	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	23.24	6.64	2.21	1.11	0.55	2.77	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	22.27	8.13	1.06	1.41	0.35	2.47	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	18.44	3.69	0.74	2.58	0.74	1.11	1.48	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	13.82	3.45	1.15	0.00	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	25.71	5.76	1.15	0.77	0.00	1.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	19.25	3.40	0.57	2.26	0.57	1.13	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	15.59	8.20	0.82	0.82	0.00	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	20.79	6.78	0.90	1.81	0.45	1.36	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	22.26	5.75	0.00	2.87	0.00	0.00	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	4.48	0.75	2.24	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	21.92	3.34	0.37	2.60	1.49	0.74	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	17.66	3.45	1.72	2.15	2.15	1.29	0.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	34.25	3.43	0.86	0.86	2.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	23.32	5.66	2.00	2.33	0.67	0.33	0.33	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	29.56	4.83	0.60	0.60	0.00	1.21	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	25.60	3.55	0.71	0.71	1.42	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	23.37	7.22	1.03	0.34	0.69	0.69	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	25.23	4.83	1.61	2.15	0.54	1.61	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	18.85	2.02	2.69	0.00	1.35	1.35	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.56	6.30	1.11	2.22	1.11	0.74	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	29.07	2.33	1.16	0.00	1.16	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	27.50	4.23	2.12	2.12	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	26.41	7.60	0.40	1.20	1.20	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.17	7.27	0.73	0.00	0.00	0.73	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	26.83	3.83	0.77	0.77	0.77	2.30	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	19.73	3.95	0.49	1.97	0.99	0.99	0.49	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	20.70	6.59	0.94	0.00	0.94	0.00	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	20.62	4.02	1.51	1.51	0.00	2.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	21.18	7.21	2.70	0.90	0.45	1.35	0.45	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	1.72	3.44	0.00	0.00	3.44	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	28.50	7.57	0.00	2.23	1.34	1.78	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	24.24	10.17	1.56	3.91	0.39	2.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	19.13	4.62	0.66	0.66	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	22.31	8.30	1.04	1.56	1.04	2.59	1.04	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	30.19	10.50	3.94	3.50	0.00	1.75	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	19.01	10.06	1.68	1.68	0.00	1.12	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	25.17	7.07	1.77	0.88	0.44	1.32	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	26.61	10.03	1.54	2.70	1.16	0.39	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	20.76	5.06	3.04	2.03	0.51	1.01	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	24.99	7.21	1.44	2.40	1.44	0.96	0.48	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	20.67	5.96	0.80	2.39	0.00	1.59	0.80	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	27.95	6.68	1.82	1.22	0.61	0.61	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	18.68	5.53	1.38	0.69	0.69	1.38	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	28.12	3.80	1.90	1.90	0.00	0.38	0.38	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	23.24	5.68	2.58	2.07	1.03	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	15.12	9.07	0.00	1.21	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	27.57	6.65	2.22	2.22	1.27	1.58	0.95	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	26.12	5.33	0.53	0.00	1.07	0.53	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	17.81	6.90	1.15	0.00	0.57	1.15	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	25.71	2.57	2.57	3.09	0.51	1.03	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.88	3.54	0.71	1.41	1.41	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	27.24	5.67	1.13	0.57	0.57	1.13	0.57	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	22.88	8.74	0.42	0.42	0.83	0.42	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	23.49	7.05	0.78	1.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	17.54	5.01	0.84	2.09	0.00	0.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	20.44	8.83	0.00	1.86	0.46	0.00	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	18.06	4.68	0.67	0.67	1.34	0.67	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	25.13	7.48	1.60	1.07	1.60	1.07	1.60	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	26.27	6.47	0.81	1.62	0.40	2.42	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	25.70	1.84	0.00	0.00	2.75	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	28.45	2.67	0.89	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	30.20	2.85	2.28	0.57	0.00	1.14	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	26.07	6.14	1.53	2.30	0.77	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	29.55	6.57	1.09	1.09	0.00	1.09	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	19.60	5.35	0.89	0.45	0.45	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	21.58	4.42	0.52	0.78	1.04	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	21.88	2.65	1.33	0.00	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	0.00	2.08	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	25.30	11.17	0.46	0.46	1.14	0.68	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	12.85	4.77	0.18	0.92	0.00	0.18	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	19.92	7.73	0.66	0.39	0.39	0.52	0.52	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.97	2.12	0.53	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	16.64	8.40	0.79	0.48	0.63	0.95	0.79	0.00
Mallassez-derived cells, donor3	11930-125I4	14.04	7.09	1.25	0.56	0.28	0.56	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	32.88	5.88	4.58	1.59	1.79	2.39	1.69	0.10
Mammary Epithelial Cell, donor2	11350-117G9	16.21	6.37	2.03	0.87	1.45	0.58	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	7.73	2.00	1.00	0.00	0.75	0.75	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	2.03	86.78	35.25	0.68	0.00	13.56	0.00	0.00
Mast cell, donor1	11563-120D6	37.31	19.25	3.03	1.19	0.43	1.51	1.08	0.11
Mast cell, donor2	11565-120D8	117.38	35.66	3.27	1.49	4.46	3.27	3.27	0.00
Mast cell, donor3	11566-120D9	142.05	49.30	4.73	0.90	7.65	5.40	3.15	1.35
Mast cell, donor4	11567-120E1	112.05	42.02	5.32	1.60	3.19	4.96	2.30	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	31.60	13.64	2.44	1.66	1.77	0.67	0.89	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	32.69	16.34	4.09	1.75	0.58	3.50	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	30.17	13.54	0.92	0.46	1.15	0.23	0.92	0.34
Mast cell, expanded, donor8	11941-126A6	63.26	28.95	4.02	1.51	2.01	2.34	0.67	1.00
Melanocyte - dark, donor1	11502-119F8	15.42	7.96	0.10	0.50	0.90	0.10	0.40	0.30
Melanocyte - dark, donor2	11582-120F7	10.04	5.88	0.00	1.04	0.35	0.00	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	25.93	10.58	1.01	1.23	0.29	0.87	0.29	0.22
Melanocyte - light, donor1	11274-116H5	11.75	4.47	0.71	0.24	0.47	0.00	0.47	0.00
Melanocyte - light, donor2	11351-117H1	6.82	1.36	0.00	0.00	0.00	1.36	1.36	0.00
Melanocyte - light, donor3	11423-118G1	10.41	4.34	0.87	0.00	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	23.95	11.87	0.62	1.04	0.31	0.31	0.62	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	15.06	8.61	1.61	0.81	0.00	0.81	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	18.48	18.48	0.80	1.34	0.80	0.27	0.00	0.00
Meningeal Cells, donor1	11493-119E8	16.62	6.70	0.50	0.00	0.12	0.25	0.12	0.00
Meningeal Cells, donor2	11573-120E7	14.97	5.28	0.44	0.00	0.44	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	25.51	12.71	1.30	1.30	0.49	0.16	0.33	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	15.68	5.70	0.00	0.57	0.00	0.00	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	16.81	8.05	0.70	0.60	0.91	0.40	0.40	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	1.31	0.00	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	15.07	4.31	1.44	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	17.36	4.45	0.64	1.48	0.21	0.64	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	9.55	3.52	0.00	0.50	1.01	0.00	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	4.61	0.44	0.88	0.00	0.22	0.00	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	0.73	0.73	0.00	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.55	1.02	0.20	0.00	0.20	0.20	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	17.04	4.16	0.28	0.14	0.55	0.14	1.39	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.46	2.97	0.37	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	24.74	6.97	1.84	1.05	0.53	0.79	1.05	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.12	0.30	0.00	0.30	0.00	1.19	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	2.34	0.00	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	1.28	0.64	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	18.43	4.61	1.06	0.00	0.00	0.35	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	18.76	8.44	0.00	0.00	0.63	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	11.61	2.18	0.00	0.73	0.73	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	18.56	5.04	0.80	1.86	1.06	0.27	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	11.01	5.00	1.50	0.00	1.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	14.45	8.60	1.16	0.72	0.58	0.43	0.72	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	18.90	9.45	4.05	0.00	0.00	2.70	4.05	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	17.49	14.04	2.46	0.49	0.74	0.49	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	14.43	6.77	1.47	0.88	0.29	0.59	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	0.00	6.91	0.00	0.00	0.00	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	16.43	19.22	0.62	1.24	0.00	0.62	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.58	6.64	1.24	1.04	0.41	0.83	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	32.42	11.58	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	15.27	11.01	1.25	0.50	0.75	0.50	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	17.69	6.98	1.86	0.00	0.47	0.47	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	38.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	10.77	11.38	0.20	0.81	0.20	0.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.07	5.94	1.98	1.98	0.40	0.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	9.73	5.31	0.88	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.84	6.46	2.28	1.52	0.00	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	25.00	9.21	0.00	0.00	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.61	11.25	0.21	1.49	0.42	0.42	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	12.89	4.60	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.15	9.24	0.30	0.00	0.30	0.60	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	5.03	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	6.02	12.29	0.75	0.00	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	8.08	6.42	0.95	0.48	0.95	0.71	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.72	12.16	1.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	9.90	12.20	0.46	0.69	0.23	0.00	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.68	7.57	0.21	0.42	0.42	0.84	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.99	12.23	0.61	0.41	0.41	0.82	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	5.79	10.30	0.21	1.72	0.21	0.64	0.00	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	9.56	7.78	0.89	0.44	0.44	0.44	0.89	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.88	10.95	0.22	1.53	0.00	0.66	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	14.19	11.15	1.01	0.00	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	13.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.33	17.12	0.00	0.00	0.27	0.54	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	9.70	8.23	0.88	0.00	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	13.08	11.99	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.13	13.46	0.00	0.96	0.00	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.40	11.61	0.00	1.20	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	10.97	0.00	0.00	0.00	0.00	1.37	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.01	14.52	0.00	1.50	0.00	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	10.19	0.00	0.00	0.00	2.04	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	11.39	11.39	0.44	0.44	1.31	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	16.55	6.62	2.21	0.00	0.00	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.65	13.45	0.00	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.17	15.37	0.50	1.24	0.25	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	17.40	11.13	0.70	0.00	0.70	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	39.78	11.05	4.42	0.00	0.00	0.00	4.42	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.50	8.89	0.00	1.37	0.68	0.34	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	18.82	8.75	0.88	0.00	0.88	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	25.92	14.56	1.78	0.00	0.71	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	9.82	10.38	0.56	0.56	0.84	0.56	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	19.12	8.31	0.00	0.42	0.42	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	23.89	9.91	0.58	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	13.88	14.78	0.60	0.30	0.30	0.30	0.30	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	19.20	10.85	1.25	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	21.24	13.85	1.85	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	24.47	9.68	2.85	0.57	1.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.07	15.61	1.52	0.28	0.28	0.41	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	11.14	13.48	1.04	0.52	0.26	0.26	0.52	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	22.31	9.87	1.29	0.00	0.43	0.00	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	25.41	8.26	0.64	0.00	0.00	1.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	19.22	15.75	0.53	0.53	0.53	0.80	1.07	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	24.84	14.07	1.50	0.60	0.90	0.60	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	21.19	13.28	0.99	0.00	0.57	0.57	0.71	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	12.74	14.65	1.59	1.91	0.64	0.00	0.64	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.55	10.17	0.88	0.00	1.11	0.66	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	26.16	8.72	0.38	0.00	0.76	0.38	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	18.18	16.76	0.28	0.57	0.57	0.28	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	16.96	11.80	0.98	1.47	0.49	0.98	0.98	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	30.63	7.17	0.00	0.00	1.96	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	17.64	15.88	0.88	0.88	1.18	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	20.76	10.09	1.73	0.58	0.29	0.58	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	27.61	11.95	1.24	0.00	0.00	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	24.42	19.95	1.19	0.60	1.19	0.60	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	22.60	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	7.13	0.00	0.00	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	9.86	12.16	0.99	2.96	0.66	0.00	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	2.10	16.83	0.00	0.00	0.00	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	8.70	9.29	1.38	0.79	0.20	0.40	0.00	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	11.18	16.76	1.86	0.00	0.93	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	6.38	12.02	0.75	1.50	0.00	0.38	1.50	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	6.92	7.72	0.27	0.27	0.53	0.53	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	11.42	13.23	0.34	0.23	0.57	0.23	0.11	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	6.63	0.00	1.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	10.63	15.76	0.37	0.73	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	21.78	0.00	6.22	1.56	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	15.50	17.10	0.53	1.07	0.00	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	7.73	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	4.04	15.15	1.01	2.02	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.90	15.18	0.00	1.26	0.00	0.84	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	25.88	28.60	2.72	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.27	9.54	0.00	0.64	0.00	0.64	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	10.53	12.15	0.81	0.00	0.81	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	7.55	4.53	0.00	0.00	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	114.20	68.52	28.55	0.00	5.71	22.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	26.10	13.05	0.00	0.00	9.79	0.00	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	19.01	4.75	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	25.10	0.00	0.00	0.00	12.55	0.00	25.10
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	17.23	5.60	0.65	1.29	0.43	0.65	0.65	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	17.77	8.36	0.00	0.00	1.05	0.00	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	5.34	2.67	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	6.68	0.83	0.83	0.00	0.42	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	25.29	2.47	0.38	0.76	1.52	0.57	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	27.13	23.94	0.00	0.00	3.19	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.04	2.72	0.68	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	5.51	3.68	0.00	0.00	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	2.51	4.19	1.26	0.00	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	4.65	2.32	0.70	0.70	0.23	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4.86	3.78	0.54	0.27	0.27	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	17.03	8.62	1.26	0.00	1.05	0.63	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	22.27	0.00	11.13	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	5.46	4.47	0.00	0.00	0.00	0.00	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.58	3.79	0.81	0.27	1.08	0.27	1.08	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	2.95	2.27	0.68	0.23	0.45	0.00	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	3.76	3.43	0.82	0.49	0.33	0.16	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	17.68	11.48	0.36	0.36	0.55	0.36	0.55	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	3.18	4.77	0.00	0.00	0.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.00	6.00	0.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	23.30	4.59	0.98	0.98	0.98	0.66	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	1.95	3.09	0.16	0.33	0.00	0.33	0.49	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.40	13.93	0.71	0.88	0.71	0.35	0.71	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	7.03	0.70	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	6.44	4.60	1.38	0.46	0.00	0.00	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	4.50	5.46	0.96	0.64	0.00	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	23.80	3.45	0.69	2.07	2.07	0.00	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	128.95	12.64	5.06	5.06	2.53	2.53	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	21.61	11.58	0.45	0.45	0.22	0.45	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	2.54	1.69	0.42	1.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	11.39	5.70	0.95	1.19	0.24	0.47	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	2.15	3.43	1.72	0.43	0.43	0.00	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	90.28	54.17	0.00	18.06	0.00	9.03	0.00	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.00	5.33	0.67	0.00	0.00	0.33	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.27	9.02	0.00	0.00	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.95	2.38	0.40	0.00	0.40	0.79	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	1.86	2.79	0.00	0.93	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	13.24	2.65	0.38	0.00	0.38	0.38	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.56	1.96	0.98	0.00	0.33	0.00	1.30	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.54	3.49	0.00	0.44	0.87	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	16.73	5.88	1.36	0.00	1.81	0.45	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	1.76	0.00	0.00	0.00	0.00	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.98	2.66	0.00	0.00	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	4.96	3.47	0.00	1.49	0.50	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.89	4.59	0.38	0.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	15.42	3.63	0.60	0.00	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	15.03	8.40	0.44	1.11	1.11	1.11	0.88	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.03	4.74	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	66.42	10.22	0.00	10.22	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	4.27	3.05	0.00	0.61	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	4.72	3.15	0.94	0.63	0.31	0.31	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	4.54	4.54	0.00	0.30	0.00	0.30	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	8.70	1.58	0.00	0.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	36.28	7.94	0.00	4.53	2.27	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	40.46	5.06	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	9.57	3.48	1.49	0.50	0.99	0.62	0.37	0.37
Myoblast, donor2	11322-117D8	16.49	4.99	1.34	1.73	1.15	1.15	0.38	0.77
Myoblast, donor3	11398-118D3	15.64	5.38	1.18	0.84	0.50	0.34	1.01	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	30.06	9.34	0.73	1.75	0.88	0.58	0.58	0.00
Natural Killer Cells, donor1	11230-116C6	47.67	47.36	5.23	4.31	1.23	1.54	1.54	6.15
Natural Killer Cells, donor2	11311-117C6	53.98	62.12	6.63	5.43	2.11	1.21	1.51	9.65
Natural Killer Cells, donor3	11387-118C1	53.93	56.87	5.34	3.13	1.47	1.84	1.10	12.88
Neural stem cells, donor1	11275-116H6	33.03	38.11	2.18	2.54	0.73	1.81	1.09	0.00
Neural stem cells, donor2	11352-117H2	38.51	34.66	5.78	0.00	1.93	3.85	1.93	1.93
Neurons, donor1	11494-119E9	23.90	25.03	1.14	1.14	1.14	4.55	1.14	0.00
Neurons, donor2	11574-120E8	36.33	14.75	1.32	0.88	0.44	0.44	0.22	0.22
Neurons, donor3	11655-122E8	13.15	19.73	4.11	0.82	1.64	1.64	2.47	0.00
Neutrophils, donor1	11233-116C9	183.74	64.96	14.85	25.06	6.50	5.57	1.86	2.78
Neutrophils, donor2	11314-117C9	139.15	72.47	23.19	52.18	2.90	2.90	0.00	20.29
Neutrophils, donor3	11390-118C4	299.31	78.19	18.33	9.16	12.83	7.33	1.83	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	23.75	11.75	1.07	1.19	0.36	0.83	0.71	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	18.56	4.23	0.65	0.33	0.33	0.00	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	14.24	5.01	0.20	0.00	0.40	0.20	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	7.16	9.22	0.55	1.24	0.00	0.41	0.55	0.41
Olfactory epithelial cells, donor2	11934-125I8	9.41	9.41	1.45	1.59	0.58	0.29	0.87	0.58
Olfactory epithelial cells, donor3	11935-125I9	13.17	6.13	0.57	1.59	0.68	0.34	0.68	0.11
Olfactory epithelial cells, donor4	11936-126A1	19.38	9.45	0.78	0.88	1.07	0.29	0.68	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	18.66	9.03	0.60	0.60	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	14.25	2.98	1.49	0.00	0.64	0.43	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	8.00	3.43	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.31	6.21	0.62	0.62	0.00	1.24	1.24	0.00
Osteoblast, donor1	11277-116H8	7.82	2.15	0.78	0.00	0.20	0.20	0.20	0.00
Osteoblast, donor2	11354-117H4	14.75	2.81	1.40	2.11	0.70	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	19.73	5.69	1.07	0.89	0.53	1.07	0.53	0.18
Pancreatic stromal cells, donor1	11249-116E7	18.03	6.40	1.10	0.59	0.93	0.42	0.42	0.00
Pericytes, donor1	11491-119E6	5.01	2.56	0.00	0.11	0.33	0.22	0.22	0.11
Pericytes, donor2	11571-120E5	7.02	1.36	0.23	0.00	0.00	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	5.49	1.83	0.81	0.00	0.41	0.00	0.41	0.00
Perineurial Cells, donor1	11499-119F5	22.94	6.78	0.23	0.57	0.23	0.00	0.45	0.00
Perineurial Cells, donor2	11579-120F4	17.76	7.08	1.38	0.18	0.55	0.55	1.47	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	70.76	40.80	5.10	1.91	1.59	0.96	0.64	4.46
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	43.83	43.59	3.43	1.96	0.98	1.71	1.22	5.88
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	52.80	44.39	2.98	1.16	1.04	2.20	0.13	2.07
Placental Epithelial Cells, donor1	11278-116H9	10.52	3.59	1.20	0.00	0.24	0.48	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	9.98	2.22	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	8.44	4.52	0.20	0.00	0.20	0.20	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.33	5.70	1.27	1.90	0.32	1.27	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	16.32	4.69	2.25	0.75	0.75	0.94	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.27	3.65	1.83	0.39	0.65	0.13	0.26	0.91
Preadipocyte - breast, donor2	11328-117E5	13.73	6.53	1.58	0.90	0.00	0.90	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	17.05	8.21	2.45	0.53	1.39	0.85	0.53	0.11
Preadipocyte - omental, donor2	11329-117E6	9.17	7.86	1.31	0.87	1.31	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	21.49	5.73	2.44	4.01	0.57	0.72	0.86	0.14
Preadipocyte - perirenal, donor1	11469-119C2	12.80	2.95	1.97	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	9.52	1.84	0.31	0.00	0.31	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	22.67	4.07	1.06	1.24	1.06	1.59	0.00	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	16.18	5.96	1.36	0.85	0.51	1.02	0.17	0.17
Preadipocyte - visceral, donor1	11280-116I2	19.47	5.50	1.77	0.28	0.84	1.12	0.09	0.09
Preadipocyte - visceral, donor2	11357-117H7	15.65	7.36	1.84	1.84	0.00	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	17.35	3.13	1.67	0.63	1.15	0.94	0.42	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	42.69	12.82	2.87	3.77	1.66	1.66	0.15	0.75
Prostate Epithelial Cells, donor2	11331-117E8	13.14	3.66	0.54	0.81	0.68	0.68	0.14	0.14
Prostate Epithelial Cells, donor3	11404-118D9	29.33	3.67	1.41	1.90	0.73	0.92	0.12	0.00
Prostate Stromal Cells, donor1	11254-116F3	13.67	4.90	1.37	0.80	1.03	0.91	0.68	0.11
Prostate Stromal Cells, donor2	11332-117E9	19.36	7.71	1.61	0.90	0.54	0.72	0.90	0.18
Prostate Stromal Cells, donor3	11405-118E1	15.33	5.53	1.77	0.94	0.73	0.31	0.21	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.03	1.82	0.00	0.36	0.00	0.00	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	18.30	6.72	0.35	0.90	0.69	0.21	0.21	0.35
Renal Epithelial Cells, donor1	11517-119H5	6.59	0.51	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	2.85	1.42	0.71	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	22.13	8.05	0.53	2.22	0.32	0.32	0.32	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.77	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.41	2.96	0.54	0.00	0.27	0.27	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	20.65	6.22	0.89	1.33	1.55	0.89	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	2.66	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.50	1.98	0.22	0.22	0.44	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	7.52	2.51	0.00	0.00	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.05	1.39	0.00	0.00	0.00	0.28	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	11.81	1.88	0.81	0.00	0.27	0.54	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.48	2.95	0.42	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.33	2.12	0.00	0.00	0.19	0.19	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	23.08	5.19	0.00	1.04	1.04	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	10.80	1.42	0.28	0.28	0.28	0.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	3.09	1.03	0.00	0.00	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	20.83	12.04	0.00	1.00	0.75	0.25	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	71.09	17.51	3.07	1.60	2.41	0.53	0.80	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	19.65	5.36	2.68	1.79	0.00	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	26.42	8.81	1.10	3.85	0.55	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	59.75	15.08	0.58	1.74	2.90	3.48	1.74	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	54.22	9.49	0.52	0.26	2.60	1.56	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	33.07	8.44	0.40	0.70	0.99	0.79	0.20	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	34.69	10.48	1.23	1.34	1.00	0.45	0.22	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	41.18	11.41	0.50	1.74	1.12	1.12	0.50	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	25.17	9.56	0.70	1.75	0.82	0.70	0.58	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	35.83	12.48	0.69	3.00	1.62	1.16	0.23	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	38.33	7.94	0.82	1.10	1.10	0.68	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	26.02	9.08	0.91	1.51	0.61	0.91	0.45	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	34.94	6.81	1.08	0.00	0.36	0.72	0.36	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	32.28	10.33	0.43	0.29	1.00	1.00	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	28.97	6.65	0.64	0.97	1.40	0.86	0.00	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	32.53	8.85	0.66	0.89	2.21	1.33	0.00	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	39.96	12.43	0.76	0.76	0.57	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	29.44	10.53	0.84	0.47	0.84	0.47	0.37	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	41.72	12.21	0.56	3.57	2.63	0.38	0.19	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	40.08	9.55	1.19	0.53	1.19	0.80	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	38.55	9.44	1.17	1.07	1.17	0.88	0.49	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	29.60	11.27	0.95	2.10	0.76	0.38	0.19	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	37.06	11.21	1.60	0.53	0.64	1.07	0.43	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	30.83	12.61	2.52	1.68	1.40	0.56	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	36.91	12.48	1.37	1.54	0.68	1.20	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.74	13.31	1.46	0.00	1.46	1.28	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	26.86	11.16	1.47	0.98	0.61	0.37	0.49	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	27.40	11.82	1.34	1.75	1.07	0.94	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	33.02	12.50	1.42	0.71	0.94	0.94	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	24.80	16.27	1.79	1.79	0.79	1.39	0.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	35.78	15.43	1.87	0.47	1.87	0.23	0.00	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	29.44	13.27	0.83	0.62	0.83	0.83	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	27.65	13.49	2.21	1.77	0.66	0.88	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	27.36	14.00	2.30	1.04	1.04	0.21	0.42	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	34.45	14.67	1.88	0.81	1.35	0.94	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	39.68	13.28	1.36	0.00	0.85	1.19	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	39.52	15.81	1.54	0.77	3.08	0.39	0.39	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	40.75	11.00	1.03	1.03	0.86	0.34	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	36.62	10.01	2.06	0.55	1.37	0.96	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	41.70	11.66	1.48	1.64	1.31	1.31	0.49	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	37.49	8.52	1.70	0.85	1.02	0.51	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	33.88	8.88	1.92	1.48	1.04	1.18	0.59	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	40.25	7.46	1.33	0.27	2.13	0.53	0.27	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	42.86	9.82	0.55	0.69	0.83	0.69	0.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	41.43	8.57	0.71	0.24	0.71	1.43	0.24	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	45.95	12.50	1.61	1.21	1.41	1.41	0.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	36.54	8.76	0.85	1.04	1.04	1.04	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	42.62	9.08	0.35	4.89	0.35	1.75	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	41.40	11.48	0.91	0.30	0.60	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	38.67	7.47	0.61	0.73	0.73	1.10	0.49	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	78.60	17.76	2.47	0.73	1.02	1.60	0.44	2.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	43.81	10.34	1.22	0.00	1.83	1.22	1.22	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	44.61	6.93	1.51	0.60	0.90	1.21	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	35.51	4.98	1.13	2.26	1.36	1.13	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	43.73	7.49	0.90	3.00	0.30	1.20	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	47.47	8.86	1.30	0.24	0.94	1.53	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	29.88	8.11	2.35	0.21	1.28	1.71	0.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	60.10	8.41	2.40	0.60	1.20	1.80	0.00	0.00
Schwann Cells, donor1	11498-119F4	7.15	2.07	0.19	0.00	0.19	0.19	0.19	0.00
Schwann Cells, donor2	11578-120F3	17.01	6.80	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	16.43	6.79	0.22	1.53	0.44	0.88	0.22	0.44
Sebocyte, donor1	11220-116B5	12.05	5.48	0.55	0.55	0.55	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	5.06	4.14	0.00	1.38	0.00	0.92	0.00	0.00
Sebocyte, donor3	11378-118B1	5.98	1.44	0.00	0.00	0.21	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	24.85	4.97	3.31	0.00	0.00	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	19.77	14.12	0.00	2.82	0.00	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	25.78	9.33	0.53	0.97	1.06	0.35	0.44	0.09
Skeletal Muscle Cells, donor2	11358-117H8	11.57	0.00	0.72	0.00	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	21.74	3.34	1.67	0.00	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	21.68	7.54	2.36	0.47	0.63	0.16	0.31	0.47
Skeletal Muscle Cells, donor5	11455-119A6	15.61	6.24	0.59	0.15	0.30	0.74	0.59	0.15
Skeletal Muscle Cells, donor6	11459-119B1	24.62	6.93	0.92	0.00	0.62	1.08	0.77	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	20.67	10.58	1.01	1.39	0.76	0.88	0.76	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.55	8.13	0.86	0.86	1.43	1.00	0.86	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	23.31	8.53	1.29	0.99	0.69	0.40	0.40	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	20.98	5.90	0.84	1.01	1.10	0.08	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	17.37	1.45	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.57	3.85	0.69	0.00	0.14	0.28	0.00	0.00
Skin - palm, donor1	10286-104F7	91.33	32.23	0.00	0.00	5.37	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.22	2.02	0.43	0.58	0.29	0.43	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	35.17	4.09	3.27	3.27	2.45	1.64	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.58	2.21	0.26	0.78	0.13	0.52	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	18.07	5.00	0.97	1.11	0.56	0.83	0.56	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	22.65	9.99	1.83	0.28	0.98	0.56	0.28	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	44.62	8.67	2.54	0.00	1.90	1.69	1.90	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	32.38	6.00	1.80	1.05	0.97	1.20	0.30	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	17.28	3.70	0.31	0.31	1.23	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	15.79	2.45	1.33	0.00	0.67	0.89	0.67	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	11.17	1.76	0.00	0.00	0.00	0.59	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	14.81	2.21	0.44	0.00	0.44	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	4.33	2.36	1.97	0.00	0.39	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.13	3.09	1.55	0.00	0.00	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	19.01	9.01	1.00	2.00	1.00	2.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	9.71	1.46	0.53	0.53	0.53	0.00	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	16.85	4.21	0.44	1.77	1.33	0.44	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	21.13	5.25	1.66	0.26	0.51	0.64	0.38	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	19.21	4.56	0.65	0.00	0.00	0.33	0.98	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	17.42	6.20	1.48	0.30	0.30	0.59	0.89	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	16.66	4.70	0.43	0.43	0.28	0.28	0.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.07	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	28.31	10.05	1.22	3.35	0.91	0.30	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.84	4.04	0.51	0.00	0.00	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	55.09	0.00	0.00	0.00	6.12	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.54	3.81	0.00	0.00	0.00	0.48	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.75	5.01	1.03	0.44	0.29	0.59	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	15.28	4.95	0.43	0.22	0.43	0.43	0.43	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	13.96	5.35	0.31	0.94	0.63	0.21	0.42	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	5.26	1.39	0.93	0.00	0.15	0.31	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	1.08	2.16	0.00	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.06	1.20	0.60	0.00	0.00	0.30	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.78	1.71	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	25.36	8.64	0.63	0.94	0.63	0.00	1.57	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	14.39	4.33	1.51	0.91	0.70	0.50	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	16.16	5.69	0.68	0.68	0.23	0.46	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.25	1.81	0.00	0.60	0.00	0.60	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	27.55	6.36	0.79	0.53	0.53	0.26	1.32	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	18.78	4.39	1.07	0.13	0.67	0.67	0.40	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.40	5.51	1.25	1.13	0.50	0.88	0.38	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	7.61	4.31	1.27	0.25	0.00	1.01	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	12.51	4.07	1.36	0.15	0.60	0.00	0.75	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	11.25	0.75	0.00	0.00	0.00	0.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	81.41	1.29	0.00	0.00	3.88	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	18.60	2.79	0.93	0.93	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	11.11	4.04	1.01	1.51	0.50	0.00	0.00	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.34	4.70	1.57	0.00	0.31	0.63	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.95	0.29	0.00	0.29	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	22.83	5.08	1.08	0.25	0.67	0.83	0.75	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	12.61	4.67	0.47	1.40	1.40	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	7.20	1.44	0.43	0.29	0.43	0.29	0.43	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	8.41	3.31	0.51	0.25	0.00	0.00	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.26	1.50	0.38	0.19	0.19	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.01	5.31	0.70	0.70	0.42	0.28	0.84	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	12.99	4.27	0.08	0.34	0.50	0.25	0.34	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.29	1.43	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	5.38	2.20	1.47	0.00	0.49	0.00	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	19.00	4.42	1.33	0.22	0.88	1.99	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	14.04	2.63	0.59	0.00	0.59	0.29	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.35	4.66	1.17	0.39	0.39	0.78	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.67	3.70	0.79	1.59	0.79	0.79	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	10.04	4.09	0.37	1.12	0.00	1.12	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	14.73	5.39	1.80	1.08	1.44	0.36	0.72	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	6.81	1.42	0.85	0.85	0.00	0.28	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	17.72	1.97	0.39	0.79	1.97	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	12.44	2.79	1.78	3.30	0.51	0.76	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	13.98	3.19	0.80	1.60	0.00	1.20	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	8.78	2.51	1.25	0.42	0.42	0.42	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	14.67	4.58	0.46	1.83	0.46	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	11.95	9.76	1.68	1.35	1.18	0.50	0.34	0.17
Synoviocyte, donor2	11368-117I9	13.75	9.55	0.67	0.50	0.50	0.84	0.84	0.17
Synoviocyte, donor3	11440-118H9	14.07	10.05	0.67	1.12	0.67	0.22	0.89	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	4.65	2.14	0.36	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	0.00	0.00	0.00	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	10.19	3.24	0.69	0.46	0.23	0.00	0.93	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	12.90	3.15	0.43	0.36	0.36	0.50	0.14	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	7.34	4.64	0.00	0.00	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	1.72	1.15	0.00	0.57	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	77.75	17.35	1.72	1.11	2.46	1.48	1.60	0.86
Urethra, donor2	10319-105A4	73.74	25.18	1.80	1.80	0.00	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	2.39	0.80	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	5.21	1.20	0.40	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.13	0.46	0.46	0.00	0.00	0.00	0.46	0.00
Urothelial cells, donor0	11216-116B1	26.30	6.46	0.67	1.78	0.22	0.67	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	174.40	25.80	3.56	0.89	0.89	0.89	1.78	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	194.43	32.88	2.86	1.43	5.72	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	157.44	28.75	1.37	5.48	2.74	0.68	0.68	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	87.81	29.61	1.38	1.38	1.38	0.34	0.69	3.44
Whole blood (ribopure), donor090325, donation2	12177-128I8	81.34	27.89	3.49	1.74	2.91	0.58	0.00	2.91
Whole blood (ribopure), donor090612, donation1	12182-129A4	156.19	30.20	2.08	0.00	5.21	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	194.57	33.96	0.00	0.92	2.75	1.84	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	120.50	35.60	0.91	2.74	2.74	0.00	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	26.77	8.14	1.85	0.86	1.23	0.74	0.49	0.25
Wilms' tumor cell line:HFWT	10597-108E3	80.96	22.00	0.88	0.00	2.64	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	16.76	2.79	0.28	0.28	1.12	0.00	0.56	0.28
achilles tendon, donor2	10292-104G4	37.20	24.80	4.13	0.00	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	18.36	9.43	1.78	3.06	0.76	0.51	0.51	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	35.06	13.70	1.63	1.39	1.16	1.63	0.93	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	52.35	23.15	4.15	2.37	1.07	3.92	0.83	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	37.28	8.44	2.18	3.81	2.45	1.09	0.54	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	22.77	12.93	0.84	2.53	0.00	0.00	1.41	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	35.11	15.65	1.27	0.21	2.11	0.63	0.63	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	38.11	23.14	2.99	3.81	1.36	1.63	0.00	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	46.71	18.95	2.64	2.20	0.88	1.32	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	42.47	26.54	1.23	4.90	0.41	0.82	0.00	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	40.77	15.92	2.33	1.55	1.94	1.55	0.78	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	23.74	12.70	0.92	1.84	0.55	0.92	0.00	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	78.01	39.01	0.00	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	34.62	15.34	5.81	3.02	0.93	1.86	1.86	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	34.69	23.56	0.78	3.88	1.04	1.04	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	33.02	13.74	1.75	2.92	2.05	0.29	0.29	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	36.25	13.01	0.46	0.46	1.39	1.39	0.93	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	30.02	13.16	0.82	1.65	0.82	0.41	0.41	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.33	9.21	1.53	0.00	0.31	0.00	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	34.56	16.64	1.28	1.28	1.71	0.00	0.85	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	36.40	16.68	1.52	1.52	0.91	1.21	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	48.38	16.85	1.68	1.44	2.17	0.24	0.48	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	19.38	6.24	2.23	0.67	0.89	0.89	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	35.02	12.01	2.33	0.67	0.00	1.00	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	50.17	37.16	1.86	0.00	0.00	0.00	5.57	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	38.80	19.59	1.13	0.38	1.51	1.13	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	35.76	31.40	2.62	0.00	1.74	1.31	0.87	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	33.74	20.62	3.75	1.87	1.87	0.00	7.50	0.00
adenocarcinoma cell line:IM95m	10796-110I4	42.63	9.66	0.94	0.00	0.47	1.18	0.71	0.00
adipose tissue, adult, pool1	10010-101C1	51.50	16.60	0.78	1.09	1.40	0.93	0.62	0.62
adipose, donor1	10184-103D4	114.35	11.14	5.28	7.62	5.86	1.76	1.17	2.93
adipose, donor2	10185-103D5	22.71	2.84	1.62	1.22	0.41	0.41	1.22	1.62
adipose, donor3	10186-103D6	36.21	5.45	1.09	1.36	1.36	1.63	0.82	1.63
adipose, donor4	10187-103D7	47.67	6.93	3.47	3.47	1.73	3.47	2.60	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	24.78	3.16	0.79	0.32	1.42	0.16	0.47	0.32
adrenal gland, adult, pool1	10081-102A9	14.55	10.91	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	30.55	14.14	1.33	1.33	0.93	0.93	0.13	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	38.59	13.58	2.14	1.43	1.07	1.79	0.36	1.79
amniotic membrane cells, donor1	12235-129G3	32.92	10.20	1.85	1.85	0.23	0.93	0.00	0.93
amniotic membrane cells, donor2	12236-129G4	31.44	7.10	2.37	0.68	1.35	1.01	1.01	0.34
amniotic membrane cells, donor3	12237-129G5	61.87	11.49	1.47	2.95	1.47	0.59	0.29	0.00
amygdala - adult, donor10196	10167-103B5	47.43	36.76	1.19	0.00	2.37	1.19	2.37	0.00
amygdala, adult, donor10252	10151-102I7	101.99	28.18	1.82	5.47	3.65	1.62	2.03	0.81
amygdala, newborn, donor10223	10360-105E9	22.59	11.94	1.94	0.32	1.29	0.65	1.29	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	30.69	12.61	0.76	2.16	1.27	0.76	0.13	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	20.96	7.94	0.88	0.88	0.66	0.00	0.22	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	72.15	12.03	1.67	1.67	1.00	2.00	1.00	1.67
aorta, adult, pool1	10052-101G7	40.21	10.98	0.39	0.98	1.57	0.39	0.59	0.98
appendix, adult	10189-103D9	72.58	41.14	3.10	0.39	1.55	0.39	2.33	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	38.52	24.42	1.38	3.10	1.38	1.38	1.03	0.00
artery, adult	10190-103E1	35.33	21.74	2.72	1.36	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	19.41	10.00	0.87	1.01	0.29	0.72	0.29	0.14
b cell line:RPMI1788	10427-106D4	29.89	11.30	1.19	2.23	1.49	0.15	2.23	1.64
basal cell carcinoma cell line:TE 354.T	10702-109G9	17.76	3.88	1.66	0.83	0.28	0.55	0.55	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	20.04	9.82	0.99	0.60	1.19	0.40	0.60	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	36.15	6.70	1.17	1.67	0.84	2.01	1.67	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	29.64	8.39	0.56	1.68	0.56	1.68	0.00	0.00
bladder, adult, pool1	10011-101C2	95.06	14.34	1.41	2.17	3.26	0.76	0.87	0.54
blood, adult, pool1	10053-101G8	57.58	19.93	2.21	2.21	2.21	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	21.41	5.99	0.00	0.00	2.57	0.00	0.86	0.00
bone marrow, adult	10192-103E3	41.84	17.55	1.35	4.05	0.67	1.35	0.00	0.67
brain, adult, donor1	10084-102B3	18.45	12.30	0.00	2.05	2.05	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	61.14	29.06	2.12	4.12	2.56	1.67	2.23	0.67
brain, fetal, pool1	10085-102B4	34.73	13.36	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	81.60	21.80	2.64	1.32	3.30	1.32	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	49.43	22.72	1.75	1.37	2.62	1.87	0.50	0.12
breast, adult, donor1	10080-102A8	29.67	9.47	1.26	0.63	0.63	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	23.37	4.95	1.14	0.76	1.40	0.51	0.76	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	25.67	5.26	0.31	1.24	1.55	0.31	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	22.10	3.45	2.30	3.22	3.45	0.46	0.46	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	28.32	5.08	2.18	1.45	0.73	1.21	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	28.21	4.23	1.41	1.41	0.00	0.00	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	37.63	9.19	1.86	1.20	0.44	1.97	0.55	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	20.28	2.22	0.32	0.63	0.32	0.00	0.63	1.90
carcinosarcoma cell line:JHUCS-1	10642-109A3	52.44	33.01	1.60	3.19	1.33	1.60	1.33	1.33
caudate nucleus - adult, donor10196	10177-103C6	65.63	35.69	1.15	3.45	4.61	0.00	3.45	1.15
caudate nucleus, adult, donor10252	10164-103B2	93.54	26.27	1.34	4.02	2.51	1.34	1.51	0.67
caudate nucleus, adult, donor10258	10379-105H1	35.15	22.92	1.53	0.76	1.53	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	31.86	13.18	1.83	1.83	1.10	0.73	1.83	0.73
cerebellum - adult, donor10196	10173-103C2	177.71	90.31	2.91	5.83	0.00	2.91	5.83	2.91
cerebellum, adult, donor10252	10166-103B4	328.17	108.04	5.34	11.96	4.06	4.06	1.28	2.99
cerebellum, adult, pool1	10083-102B2	60.71	32.77	1.03	4.48	2.07	0.34	1.72	2.76
cerebellum, newborn, donor10223	10357-105E6	128.69	24.91	5.81	9.13	6.64	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	79.17	30.51	4.03	1.26	2.77	1.01	1.01	0.00
cerebrospinal fluid, donor2	10294-104G6	42.39	14.62	2.92	0.73	1.46	1.46	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	47.30	13.52	1.87	1.01	2.01	0.43	0.72	0.14
cervical cancer cell line:ME-180	10553-107I4	29.66	6.63	1.49	0.99	1.66	0.66	0.50	0.33
cervix, adult, pool1	10013-101C4	83.05	25.30	2.20	1.99	3.78	0.73	1.47	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	25.78	12.68	0.98	0.84	0.98	0.42	0.42	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	10.45	0.00	0.00	1.31	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	48.34	8.70	0.75	2.98	2.61	1.24	0.25	0.50
choriocarcinoma cell line:SCH	10785-110H2	43.62	10.60	0.99	2.59	1.23	0.49	1.72	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	55.74	6.64	1.42	0.71	1.90	1.66	1.90	0.24
chorionic membrane cells, donor1	12238-129G6	35.90	4.56	1.42	3.13	1.42	0.00	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	27.14	6.46	1.29	0.99	0.89	0.50	0.80	0.10
chorionic membrane cells, donor3	12240-129G8	38.46	9.89	0.55	3.30	1.65	1.10	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	16.16	10.10	4.04	0.00	0.00	6.06	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	28.24	19.59	2.50	1.15	1.54	2.31	0.38	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	27.88	9.71	0.63	0.84	0.63	0.21	1.27	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	26.71	7.96	1.28	1.80	1.28	1.54	1.03	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	36.77	7.50	0.97	0.97	1.45	0.97	1.21	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	37.67	7.53	1.02	1.83	0.41	0.20	0.20	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	38.57	7.95	0.88	2.06	1.18	0.59	2.06	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	45.35	27.11	1.04	1.04	0.78	0.52	2.87	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	28.34	5.71	0.46	1.60	0.69	0.00	0.46	0.69
clear cell carcinoma cell line:TEN	10636-108I6	27.24	7.81	0.87	0.69	0.69	0.17	0.35	0.17
colon carcinoma cell line:CACO-2	10513-107D9	44.85	15.56	1.83	1.46	1.28	1.46	2.38	0.73
colon carcinoma cell line:COLO-320	10420-106C6	53.21	13.30	1.14	3.04	1.14	0.00	1.14	0.76
colon, adult, donor1	10082-102B1	28.56	5.95	0.00	0.00	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	83.07	18.45	3.17	0.35	2.23	2.82	0.47	1.06
colon, fetal, donor1	10070-101I7	44.50	11.74	3.09	1.24	1.85	2.47	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	366.68	100.84	18.33	0.00	4.58	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	56.09	34.84	8.07	3.40	0.85	11.47	2.55	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	31.09	11.32	3.02	1.21	0.45	2.87	0.91	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	26.93	14.10	2.26	1.41	1.13	1.69	0.56	1.55
corpus callosum, adult, pool1	10042-101F6	83.47	30.29	2.99	1.22	2.99	1.11	1.99	0.33
cruciate ligament, donor2	10295-104G7	64.03	15.40	2.43	1.62	2.43	2.43	0.00	3.24
diaphragm, fetal, donor1	10069-101I6	33.71	12.04	0.00	1.61	0.80	0.80	0.80	0.00
diencephalon, adult	10193-103E4	52.08	23.76	2.88	1.20	0.96	0.72	0.72	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	26.41	26.18	0.46	2.98	0.46	0.46	0.23	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	39.49	8.72	2.31	1.03	2.82	2.31	0.51	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	21.91	1.69	1.93	2.41	1.44	0.72	0.96	0.48
ductus deferens, adult	10196-103E7	52.82	22.92	5.48	1.00	2.49	5.48	0.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	33.13	20.16	2.88	0.00	2.88	0.00	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	61.79	23.54	3.68	4.41	2.21	2.21	2.21	2.94
dura mater, adult, donor1	10041-101F5	48.81	28.08	1.40	1.16	2.40	0.74	1.65	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	44.19	11.33	4.44	0.89	2.00	18.21	2.00	2.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	22.78	12.32	1.86	1.00	0.14	1.43	0.57	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	78.93	22.81	3.08	0.62	1.23	1.85	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	82.03	15.44	2.12	1.51	1.21	1.21	0.61	2.42
embryonic pancreas cell line:1C3IKEI	10606-108F3	108.37	32.42	1.54	2.16	1.54	2.16	0.93	0.31
embryonic pancreas cell line:2C6	10603-108E9	119.53	22.33	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	50.61	9.72	1.34	1.01	1.34	0.34	0.67	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	42.23	11.60	1.27	4.53	3.08	0.91	0.54	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	24.93	10.61	0.80	1.93	0.64	0.64	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	46.35	6.89	2.11	0.56	1.45	0.56	0.67	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	27.17	7.48	0.55	0.66	1.10	0.77	0.77	0.00
epididymis, adult	10197-103E8	50.44	22.61	1.88	1.47	0.42	1.26	1.05	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	14.37	6.39	0.53	1.24	0.00	0.00	0.71	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.12	10.22	2.36	0.00	0.79	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	35.51	6.55	1.31	2.49	0.79	0.52	0.66	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	38.68	9.35	1.77	2.07	1.67	1.87	0.69	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	20.95	7.73	1.12	2.69	0.90	0.45	0.34	0.45
esophagus, adult, pool1	10015-101C6	56.27	10.19	1.17	1.27	0.85	1.38	0.85	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	65.87	20.66	1.88	1.00	4.38	1.13	1.63	0.00
eye - muscle inferior rectus, donor1	10272-104E2	125.56	31.39	4.83	0.00	4.83	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	44.19	12.63	0.00	2.10	4.21	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	80.36	19.35	0.00	0.00	1.49	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	67.64	21.78	1.15	0.00	2.29	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	49.55	23.32	0.00	0.00	2.91	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	49.83	16.02	0.51	2.80	0.51	0.25	2.03	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	16.67	6.41	0.64	0.77	0.51	0.13	0.77	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	34.90	6.89	2.61	0.95	1.42	0.71	0.47	0.24
frontal lobe, adult, pool1	10040-101F4	83.88	33.40	3.47	2.53	4.79	1.41	1.97	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	49.24	6.91	2.10	2.70	1.50	0.60	0.90	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	36.48	7.13	0.64	0.64	1.55	1.01	0.46	0.27
gall bladder, adult	10198-103E9	55.77	16.66	0.97	0.00	1.69	0.24	0.97	0.97
gamma delta positive T cells, donor1	11937-126A2	51.00	34.90	3.22	2.15	1.61	1.07	0.00	3.76
gamma delta positive T cells, donor2	11938-126A3	42.95	40.71	2.99	1.87	1.12	0.75	0.37	3.73
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.64	6.55	1.06	1.48	1.27	1.06	0.00	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	52.22	14.89	1.55	3.09	2.13	0.58	0.77	0.00
gastric cancer cell line:AZ521	10549-107H9	41.48	11.97	1.31	0.49	2.79	1.64	0.82	0.49
gastric cancer cell line:GSS	10560-108A2	31.12	10.98	0.00	0.92	0.92	0.00	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	76.99	9.60	0.91	2.97	0.69	0.91	1.60	4.11
giant cell carcinoma cell line:LU65	10487-107B1	21.69	4.82	1.15	1.84	0.57	0.46	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	41.85	15.96	1.68	1.40	1.40	0.28	1.68	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	61.61	8.73	5.49	0.75	1.50	3.49	1.00	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	31.77	12.46	4.01	0.95	2.43	1.58	1.37	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	30.19	13.06	3.23	1.12	1.26	2.39	0.42	0.28
glioblastoma cell line:T98G	10485-107A8	20.64	7.28	3.09	1.10	0.99	2.21	0.55	0.11
glioma cell line:GI-1	10413-106B8	32.22	13.47	1.17	1.46	0.59	0.00	0.88	0.29
globus pallidus - adult, donor10196	10175-103C4	50.29	20.41	0.73	0.00	1.46	0.00	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	164.76	39.79	1.71	4.15	5.37	0.73	1.46	1.22
globus pallidus, adult, donor10258	10367-105F7	42.45	13.69	1.37	6.85	9.58	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	24.51	21.85	2.13	0.53	0.53	0.53	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	308.34	68.52	9.79	0.00	4.89	7.34	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	10.93	0.00	0.00	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	5.23	0.00	0.00	10.45	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	35.52	9.92	1.92	1.28	1.28	0.64	0.96	0.32
hIPS +CCl2, biol_rep1	14383-156B9	38.57	9.64	0.92	0.92	2.30	0.92	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	34.75	10.06	0.46	0.46	1.83	1.37	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	26.41	7.09	0.64	0.64	1.29	0.64	1.93	0.00
hIPS, biol_rep1	14380-156B6	31.62	4.31	0.00	1.44	0.00	1.44	0.00	1.44
hIPS, biol_rep2	14381-156B7	27.43	6.86	0.00	0.69	0.69	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	47.45	20.97	1.10	1.10	0.00	1.10	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	23.56	7.76	0.86	1.44	0.29	0.00	0.29	0.00
heart - mitral valve, adult	10205-103F7	60.39	19.73	1.20	0.60	2.09	0.30	1.49	0.30
heart - pulmonic valve, adult	10206-103F8	69.29	20.40	2.09	1.31	2.35	0.26	1.83	0.00
heart - tricuspid valve, adult	10207-103F9	165.70	44.13	2.50	0.83	1.67	1.67	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	25.71	7.55	1.22	1.22	1.43	0.41	0.61	0.61
heart, adult, diseased, donor1	10051-101G6	25.98	5.96	0.00	1.28	0.43	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	111.08	8.97	0.46	0.23	2.07	0.92	1.15	0.69
heart, fetal, pool1	10046-101G1	87.48	15.61	0.72	1.75	1.64	0.62	1.64	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	22.83	4.01	2.16	0.62	0.62	0.31	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	79.67	27.35	1.19	0.00	1.19	5.95	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	29.61	12.93	0.88	2.54	1.10	1.22	0.99	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	31.07	11.29	0.73	1.94	1.34	0.49	0.85	1.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	33.25	13.84	1.41	2.32	1.11	0.81	1.62	0.40
hepatoma cell line:Li-7	10484-107A7	46.38	12.57	1.67	2.22	1.00	0.89	0.44	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	27.74	7.14	0.70	1.61	0.90	0.20	0.20	0.30
hippocampus - adult, donor10196	10169-103B7	61.51	20.82	0.95	1.89	2.84	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	128.99	35.51	2.45	7.76	3.47	0.82	1.84	0.61
hippocampus, adult, donor10258	10374-105G5	51.79	22.91	2.49	0.50	5.98	1.49	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	22.56	13.75	0.35	0.70	1.41	1.06	1.41	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	51.88	13.43	1.22	5.49	0.61	1.22	1.22	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	25.53	8.64	0.39	1.57	0.98	0.20	0.79	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	38.59	8.63	1.02	3.05	0.76	0.51	1.02	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	31.01	13.53	3.38	2.26	0.00	2.26	2.82	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	43.64	16.27	4.13	5.16	1.03	3.36	0.26	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	36.44	12.15	2.28	1.90	1.14	2.66	0.76	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	33.28	9.05	3.21	2.34	1.75	3.80	0.29	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	30.81	9.69	1.94	1.51	0.86	2.37	1.51	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	26.28	7.92	2.50	0.42	0.42	3.34	0.83	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	27.23	11.37	1.89	0.71	1.18	0.95	1.18	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	23.46	13.34	2.09	0.96	1.45	1.77	0.80	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.91	11.45	1.35	1.35	0.00	0.00	0.00	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	23.16	6.89	0.31	0.78	1.41	0.63	0.47	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	31.93	5.40	0.98	3.44	1.47	0.98	0.98	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	24.44	7.85	0.87	3.49	2.62	0.00	1.75	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	38.56	14.13	4.20	3.82	0.95	3.63	1.34	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	31.40	6.11	2.18	0.87	0.44	2.62	1.31	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	58.47	6.00	4.00	2.50	1.00	3.00	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	27.88	4.71	0.38	1.13	0.38	0.75	1.51	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	30.92	4.55	1.82	0.00	1.82	0.91	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	20.99	5.95	2.19	0.63	1.25	2.51	1.25	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	14.53	7.84	1.14	1.31	0.33	0.98	0.98	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.87	5.81	1.74	0.58	1.74	1.74	2.03	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	22.42	6.88	2.69	1.49	0.30	1.49	1.49	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	27.90	7.94	0.92	1.11	0.37	1.48	0.74	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	27.96	9.13	1.14	1.14	0.29	0.86	0.57	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	44.91	10.62	2.04	1.63	2.04	0.00	1.63	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	35.21	9.15	2.46	2.46	0.70	4.58	1.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	23.44	7.60	1.90	1.90	0.63	2.85	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	22.70	6.36	2.72	3.03	0.91	1.51	1.21	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	18.62	3.10	2.07	0.00	1.03	1.03	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	21.92	6.64	0.66	1.33	0.66	3.32	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	20.78	8.72	2.82	0.77	1.28	1.80	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	19.94	9.46	1.28	1.02	1.53	1.02	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	25.75	6.06	1.51	0.76	1.51	0.00	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	20.50	6.72	0.67	0.67	1.01	1.34	1.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	27.29	6.04	0.97	1.69	2.17	1.21	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	39.66	10.25	3.12	2.67	0.00	1.78	1.34	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	37.07	7.80	2.44	1.46	0.49	1.95	1.95	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	37.59	14.06	2.75	0.92	0.92	4.28	0.92	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	169.17	48.80	3.25	39.04	13.01	6.51	0.00	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	42.69	18.53	3.31	2.32	0.99	2.98	1.65	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	26.82	7.11	3.83	2.74	1.09	1.64	1.64	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	20.27	3.98	2.53	2.17	0.72	2.17	1.81	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	24.56	8.90	1.07	0.71	2.85	1.42	1.07	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	13.13	7.16	1.19	1.19	3.58	3.58	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	29.79	10.29	1.22	0.95	1.90	0.95	1.49	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	19.67	6.20	2.42	1.08	0.27	1.08	0.54	0.81
immature langerhans cells, donor1	11904-125F5	46.98	30.03	2.18	0.97	2.66	2.91	0.48	0.24
immature langerhans cells, donor2	11905-125F6	41.98	19.80	3.96	0.79	0.79	3.17	0.00	7.13
insula, adult, pool1	10039-101F3	71.16	31.32	2.56	1.80	2.65	1.14	2.56	0.76
keratoacanthoma cell line:HKA-1	10791-110H8	26.01	4.88	2.93	0.65	0.65	0.98	0.33	1.63
kidney, adult, pool1	10017-101C8	39.25	23.93	1.50	2.10	1.30	0.30	1.30	0.10
kidney, fetal, pool1	10045-101F9	49.23	19.03	1.84	0.50	2.12	1.20	1.63	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	38.35	15.62	2.13	0.71	0.85	0.85	2.70	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	16.17	6.77	0.83	0.55	0.83	0.41	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	66.06	13.03	1.65	1.28	2.02	0.73	0.73	0.00
left atrium, adult, donor1	10079-102A7	9.26	9.26	0.00	1.09	1.09	0.54	0.54	0.54
left ventricle, adult, donor1	10078-102A6	18.20	2.53	0.51	1.01	0.51	0.00	1.01	1.52
leiomyoblastoma cell line:G-402	10721-110A1	31.74	6.57	0.55	1.09	1.37	0.00	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	7.54	2.51	1.08	1.44	0.36	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	11.96	2.17	1.09	0.54	0.54	1.09	0.54	0.00
leiomyoma cell line:15425	10571-108B4	11.41	2.67	0.24	1.21	0.49	0.24	0.00	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	47.05	18.82	3.14	1.05	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	80.04	18.18	3.66	4.25	2.36	1.18	4.13	0.71
liposarcoma cell line:KMLS-1	10782-110G8	24.21	6.87	0.78	1.56	1.09	0.47	0.94	0.31
liposarcoma cell line:SW 872	10726-110A6	15.72	5.12	0.37	0.24	0.00	0.85	0.49	0.00
liver, adult, pool1	10018-101C9	29.66	10.70	0.81	0.65	0.65	0.32	0.00	0.16
liver, fetal, pool1	10086-102B5	13.17	11.29	0.94	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	59.79	27.12	0.73	0.73	3.50	0.87	1.46	0.44
locus coeruleus, adult, donor10252	10165-103B3	105.56	26.76	1.85	4.80	3.32	0.92	1.11	2.40
locus coeruleus, adult, donor10258	10375-105G6	17.49	16.93	1.41	3.39	0.85	0.00	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	47.11	23.55	0.00	0.84	2.10	0.00	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	28.37	10.66	0.69	0.42	0.69	0.97	0.55	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	27.58	9.65	1.38	0.00	0.69	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	25.70	8.96	2.37	0.53	0.53	2.77	0.66	0.00
lung, adult, pool1	10019-101D1	72.06	15.36	1.65	1.77	2.24	0.35	0.59	0.71
lung, fetal, donor1	10068-101I5	169.25	45.67	4.28	0.57	7.14	4.28	5.14	0.29
lung, right lower lobe, adult, donor1	10075-102A3	38.49	17.41	4.12	0.92	1.37	0.92	0.92	1.37
lymph node, adult, donor1	10077-102A5	20.35	15.15	3.31	0.47	0.00	0.00	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	29.37	14.25	1.10	1.32	0.66	0.22	0.44	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	25.51	21.28	1.81	2.11	0.60	1.81	0.00	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	57.77	18.69	3.40	0.85	3.40	0.85	2.55	0.00
mature adipocyte, donor1	12231-129F8	71.04	16.87	1.33	0.00	1.33	0.44	3.11	1.33
mature adipocyte, donor2	12232-129F9	65.79	15.98	1.66	0.21	1.87	0.42	0.21	0.83
mature adipocyte, donor3	12233-129G1	58.55	14.93	1.42	0.24	2.13	0.47	0.00	0.95
mature adipocyte, donor4	12234-129G2	64.23	14.74	0.79	0.26	1.32	1.58	0.53	1.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	41.70	10.48	2.86	0.48	2.62	1.91	1.43	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	59.79	39.48	1.13	3.38	6.77	1.13	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	128.18	34.57	3.49	6.07	4.41	0.74	2.02	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	30.18	21.60	1.27	2.54	1.27	0.64	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	52.88	18.77	2.13	2.56	0.85	0.00	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	63.28	40.84	2.19	15.36	2.53	1.01	2.53	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	145.59	33.32	1.49	3.82	4.24	0.85	1.49	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	17.34	0.00	0.00	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	28.71	28.71	57.41	0.00	0.00	14.35	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	30.87	11.13	2.51	1.08	1.08	0.72	1.08	0.36
medulla oblongata - adult, donor10196	10174-103C3	54.51	25.31	2.60	2.60	3.24	0.00	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	110.53	32.97	2.17	4.18	2.79	0.93	1.86	1.70
medulla oblongata, adult, pool1	10038-101F2	67.02	24.24	1.06	1.31	2.04	0.49	2.45	0.49
medulla oblongata, newborn, donor10223	10361-105F1	45.48	17.71	1.04	0.69	1.04	0.35	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	77.49	20.59	2.44	1.99	1.77	1.99	1.55	1.77
medulloblastoma cell line:ONS-76	10759-110E3	20.05	4.16	0.98	0.24	0.73	0.37	1.22	0.00
melanoma cell line:COLO 679	10514-107E1	14.66	5.32	1.29	0.29	0.57	1.72	0.72	0.14
melanoma cell line:G-361	10465-106H6	13.30	3.53	0.81	0.54	0.54	1.36	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	20.26	4.34	1.45	1.45	1.09	0.72	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	59.92	29.08	7.93	11.46	0.88	6.17	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	32.14	10.63	1.04	1.30	1.56	0.78	0.26	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	18.11	3.99	1.53	1.69	0.46	0.92	0.31	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.18	2.73	1.27	0.55	0.91	1.27	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	10.77	4.56	1.66	0.41	2.90	0.83	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	12.08	4.50	0.42	0.98	0.84	0.28	0.28	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.29	4.81	1.54	1.16	0.39	0.39	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	10.41	7.63	1.39	0.00	1.39	0.00	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	21.63	4.81	1.20	0.69	0.69	1.37	0.51	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	16.22	4.83	0.58	0.81	0.35	0.58	0.23	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.31	3.98	0.66	1.06	0.66	0.40	0.27	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	20.53	4.59	1.22	0.81	0.95	0.54	0.27	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	19.63	7.26	1.14	1.00	0.71	0.71	0.43	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	19.10	11.53	0.99	0.33	1.32	0.00	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	18.40	5.81	1.11	1.52	0.97	0.42	0.97	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	17.80	3.84	0.70	1.05	0.35	1.05	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	15.52	3.67	1.43	0.82	0.61	0.20	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	11.86	5.75	2.16	1.44	0.36	0.00	0.72	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.17	5.48	0.83	0.62	0.41	0.10	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.49	2.28	1.37	1.82	0.23	0.00	0.46	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	26.01	8.39	3.36	1.68	0.42	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	15.24	5.53	0.90	0.60	0.75	0.60	0.60	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	17.68	7.53	0.79	0.53	1.05	0.18	0.35	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	23.19	7.73	1.47	1.47	1.47	0.37	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	16.88	5.72	2.29	2.29	0.57	0.57	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	29.47	4.63	0.42	2.95	2.11	0.84	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	14.16	4.11	0.91	0.00	0.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	13.30	5.12	0.00	1.79	0.51	0.51	0.77	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.83	3.14	1.57	0.00	1.05	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.94	2.46	0.92	0.92	0.62	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.71	4.71	0.94	1.41	0.94	1.18	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	15.57	4.06	0.34	0.68	1.02	1.02	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	14.15	4.32	0.00	1.18	0.00	1.18	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.12	4.17	0.00	1.85	0.46	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.42	7.50	2.31	1.44	0.58	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	12.49	4.69	0.89	1.34	0.45	0.22	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	13.22	4.33	0.48	0.48	0.48	0.24	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	9.53	12.47	0.00	0.73	0.73	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.41	2.69	0.67	1.01	1.01	1.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	8.60	5.32	1.23	1.64	0.82	0.82	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.45	6.01	0.43	0.43	0.43	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	5.47	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	15.49	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.39	3.57	0.97	0.65	0.00	0.32	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	10.18	4.36	1.45	4.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	11.73	5.86	1.60	0.00	0.00	0.00	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	7.36	3.27	1.64	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.39	5.44	0.78	0.00	0.78	0.78	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	2.10	0.00	2.10	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	9.93	4.97	0.99	0.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	14.30	9.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	10.08	3.56	1.19	1.19	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	6.09	1.22	0.00	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.23	1.90	0.63	0.00	0.00	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	8.62	4.48	0.69	0.00	0.34	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	4.30	0.00	2.15	0.00	0.00	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	3.99	0.00	0.00	3.99	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	3.44	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.41	1.63	0.41	0.81	1.22	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	8.74	2.38	1.59	0.79	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	4.72	2.36	1.18	2.36	1.18	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	13.09	1.87	0.00	0.31	0.31	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	17.38	5.35	0.00	4.01	2.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	13.01	4.73	1.18	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	0.00	2.57	2.57	0.00	5.14	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	12.39	9.64	0.00	2.75	0.00	0.00	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	9.40	8.91	0.49	1.48	0.00	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	2.24	0.00	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	6.36	8.90	0.64	3.82	1.27	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.85	5.64	0.40	0.40	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	13.08	0.00	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	3.80	0.00	1.27	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	22.45	6.07	0.61	1.82	1.21	1.21	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	4.52	0.00	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	11.53	9.06	0.82	1.65	0.82	2.47	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	10.12	4.56	0.40	0.60	0.99	0.40	0.00	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	12.33	5.19	0.32	0.32	0.65	0.32	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	11.20	4.07	3.06	0.00	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	26.31	5.42	1.55	0.00	1.55	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	49.37	10.63	1.65	1.18	1.65	1.42	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	21.55	8.11	2.55	0.93	0.46	1.16	0.70	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	8.55	4.27	8.55	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	10.38	5.75	0.51	6.06	0.10	0.51	0.51	0.10
mesothelioma cell line:Mero-25	10850-111F4	23.15	7.49	2.27	1.59	0.91	0.91	0.68	0.68
mesothelioma cell line:Mero-41	10851-111F5	24.45	7.09	1.47	1.96	1.96	1.47	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	5.54	1.99	0.66	0.22	0.44	0.00	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	25.23	8.67	5.52	2.89	0.79	3.42	1.58	0.26
mesothelioma cell line:Mero-83	10854-111F8	17.02	6.30	1.19	1.02	0.51	0.34	0.85	0.34
mesothelioma cell line:Mero-84	10855-111F9	14.66	6.32	1.77	0.76	0.25	0.51	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	14.08	7.45	1.66	0.41	0.62	0.83	1.24	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	13.25	2.65	0.66	0.50	0.66	0.99	0.33	0.00
mesothelioma cell line:NCI-H226	10846-111E9	7.42	3.80	1.09	0.72	0.18	0.36	0.72	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	37.92	8.71	3.25	3.93	1.37	2.05	0.68	0.34
mesothelioma cell line:NCI-H28	10845-111E8	22.14	8.40	2.29	1.53	1.53	1.78	0.51	0.76
mesothelioma cell line:No36	10857-111G2	11.74	9.13	0.00	0.33	1.30	1.63	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	15.44	11.65	1.63	1.35	1.35	0.54	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	41.84	10.17	0.38	2.30	1.15	0.58	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	41.15	10.62	1.34	1.47	2.08	1.10	0.37	0.24
migratory langerhans cells, donor3	11903-125F4	39.31	16.15	1.26	1.08	1.08	0.18	0.72	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	35.26	5.88	0.65	3.92	0.00	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	22.47	6.99	0.00	0.64	0.21	0.64	0.42	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	56.67	8.29	1.61	0.23	0.69	2.07	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	23.41	7.61	0.57	0.95	0.00	0.95	0.57	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	38.44	16.26	0.55	1.11	1.85	0.37	0.18	0.92
myeloma cell line:PCM6	10474-106I6	22.53	16.41	1.38	2.57	0.59	1.98	1.38	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	28.92	6.09	1.01	0.00	0.00	0.51	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	17.46	5.69	1.37	0.78	0.20	1.57	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	22.84	2.23	0.11	0.56	0.67	0.56	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	23.02	1.91	0.51	0.44	0.15	0.15	0.00	0.22
nasal epithelial cells, donor2	12227-129F4	25.94	5.52	1.10	2.21	2.76	1.66	1.10	0.55
neuroblastoma cell line:CHP-134	10508-107D4	56.13	19.79	2.30	0.69	1.38	3.45	1.84	1.15
neuroblastoma cell line:NB-1	10539-107G8	54.44	23.01	3.55	1.68	1.12	0.75	1.31	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	40.07	5.06	0.63	2.11	1.48	0.00	0.42	0.84
neuroblastoma cell line:NH-12	10555-107I6	62.05	14.72	0.93	3.73	1.30	0.37	0.75	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	44.12	1.90	0.95	2.14	0.71	0.00	1.90	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	27.08	5.54	1.27	2.38	0.63	1.74	0.95	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	18.11	7.85	0.40	1.61	0.40	0.60	0.60	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	32.42	5.72	1.91	0.64	0.00	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	15.70	5.32	1.06	0.00	0.80	0.53	1.06	0.53
neutrophil PMN, donor1	12133-128D9	1175.11	104.12	14.87	0.00	0.00	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	92.96	13.28	0.00	0.00	0.00	0.00	0.00	13.28
neutrophil PMN, donor3	12141-128E8	123.12	18.94	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	109.25	27.90	7.27	6.60	2.20	2.20	1.18	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	54.43	9.61	0.80	0.80	1.60	4.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	16.99	3.85	0.00	1.28	0.64	0.64	1.28	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	18.66	6.57	0.79	1.58	0.53	0.53	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	72.27	29.62	2.34	1.59	2.81	1.12	1.69	0.09
occipital cortex - adult, donor10196	10172-103C1	96.84	37.09	0.00	0.00	2.06	0.00	8.24	0.00
occipital cortex, adult, donor10252	10163-103B1	176.58	34.35	2.68	6.17	4.29	1.34	0.81	1.88
occipital cortex, newborn, donor10223	10355-105E4	35.67	18.56	2.91	0.73	3.28	0.73	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	47.76	28.86	2.89	0.52	2.10	2.62	0.52	0.52
occipital lobe, fetal, donor1	10073-102A1	31.75	20.60	2.15	1.72	0.86	3.00	1.72	0.86
occipital pole, adult, pool1	10036-101E9	41.55	20.10	1.02	0.87	2.37	0.63	0.63	0.00
olfactory region, adult	10195-103E6	76.04	29.61	3.06	2.48	3.82	0.96	0.76	0.38
optic nerve, donor1	10277-104E7	154.08	42.02	2.00	0.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	34.40	10.37	2.39	1.48	1.25	0.80	0.46	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	37.09	8.52	0.41	1.10	1.65	0.41	0.41	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	32.34	9.48	0.85	3.05	1.02	0.68	0.68	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	20.56	7.85	2.08	1.50	1.16	2.08	0.58	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	22.05	6.76	3.53	0.88	1.18	0.88	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	52.32	24.29	0.00	0.00	2.80	0.93	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	20.15	8.27	1.48	1.91	0.42	0.85	0.64	0.64
ovary, adult, pool1	10020-101D2	56.60	22.19	1.14	1.57	1.75	0.52	1.75	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	14.85	2.02	0.55	0.37	0.00	0.18	0.18	0.00
pancreas, adult, donor1	10049-101G4	32.92	8.47	3.76	0.94	0.00	1.88	0.00	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	23.20	6.15	0.00	0.84	2.24	0.28	1.12	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	12.78	12.44	1.19	1.87	0.85	1.19	0.68	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	50.50	12.25	1.32	0.66	2.32	0.66	0.50	0.50
paracentral gyrus, adult, pool1	10035-101E8	72.49	26.45	1.19	1.92	2.75	1.10	2.38	0.37
parietal cortex, adult, donor10258	10373-105G4	46.24	22.75	0.73	5.14	0.73	0.73	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	67.71	25.39	0.00	1.88	4.70	0.00	1.88	1.88
parietal lobe, adult, donor10252	10157-103A4	153.63	25.37	3.14	6.84	3.42	1.71	0.57	1.14
parietal lobe, adult, pool1	10034-101E7	67.41	22.56	2.03	0.97	2.56	1.15	2.11	0.26
parietal lobe, fetal, donor1	10072-101I9	77.59	29.10	3.88	0.97	1.94	1.94	3.88	0.00
parietal lobe, newborn, donor10223	10356-105E5	33.65	22.06	2.24	0.37	2.24	1.87	1.12	0.00
parotid gland, adult	10199-103F1	48.72	23.43	0.62	0.00	1.23	1.23	0.62	0.00
penis, adult	10200-103F2	48.88	19.34	2.15	3.22	1.61	0.00	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	43.51	6.14	1.30	1.86	0.56	0.19	0.56	1.67
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	21.13	8.30	1.02	1.31	0.15	0.44	0.44	0.44
pineal gland - adult, donor10196	10179-103C8	73.53	27.09	0.00	3.23	2.58	0.65	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	137.39	31.98	4.15	2.37	2.37	2.37	2.96	1.18
pineal gland, adult, donor10258	10377-105G8	37.62	27.59	1.88	2.51	0.63	2.51	2.51	0.63
pituitary gland - adult, donor10196	10180-103C9	76.90	34.40	3.04	5.06	5.06	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	198.57	69.84	1.04	0.52	4.69	2.08	3.13	1.04
pituitary gland, adult, donor10258	10378-105G9	33.20	26.39	0.85	1.70	2.55	0.00	0.85	0.85
placenta, adult, pool1	10021-101D3	78.48	17.31	1.29	1.94	1.72	0.86	1.40	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	35.09	20.79	1.32	1.19	1.59	0.40	0.93	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	36.58	6.23	0.93	0.62	0.93	1.09	0.16	1.09
pons, adult, pool1	10033-101E6	55.69	30.73	1.98	2.15	3.44	0.69	2.07	0.34
postcentral gyrus, adult, pool1	10032-101E5	54.22	22.58	1.66	1.39	2.53	1.05	1.39	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	313.71	89.93	12.55	0.00	8.37	10.46	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	16.52	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	11.74	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	22.87	4.08	0.44	2.18	1.31	0.15	1.46	1.02
prostate cancer cell line:PC-3	10439-106E7	21.78	7.44	1.45	1.27	0.54	0.36	0.54	0.00
prostate, adult, pool1	10022-101D4	80.35	17.59	1.09	1.36	3.08	1.00	1.18	0.18
putamen, adult, donor10196	10176-103C5	87.11	29.27	1.42	5.43	1.65	0.71	1.18	1.42
putamen, adult, donor10252	10152-102I8	80.39	39.21	0.00	1.96	3.92	3.92	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	26.23	7.65	0.00	1.09	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	55.09	28.51	1.93	2.66	0.97	0.24	1.45	0.24
putamen, newborn, donor10223	10365-105F5	29.99	17.99	1.50	1.50	3.00	0.00	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	92.23	11.93	2.33	0.58	1.45	1.75	2.91	0.00
rectum, fetal, donor1	10067-101I4	61.20	13.91	2.78	0.00	1.39	0.00	1.39	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	29.26	5.30	2.12	1.70	1.70	0.85	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	34.38	7.46	0.83	4.56	0.83	0.00	0.83	1.66
retina, adult, pool1	10030-101E3	54.97	24.65	2.29	0.99	1.49	0.70	1.59	0.60
retinoblastoma cell line:Y79	10475-106I7	53.00	10.65	1.04	1.04	1.30	1.82	1.04	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	29.02	6.27	0.49	0.49	0.86	0.37	0.74	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	44.15	12.09	1.12	0.56	1.97	1.12	0.28	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	37.89	7.58	1.52	0.00	0.76	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	15.21	7.77	0.32	0.97	0.32	0.81	0.65	0.00
salivary acinar cells, donor2	11772-123I8	22.17	8.26	1.38	1.38	0.55	2.07	0.55	0.14
salivary acinar cells, donor3	11773-123I9	56.27	16.55	3.31	0.66	0.00	2.65	3.97	0.00
salivary gland, adult, pool1	10093-102C3	48.04	20.59	3.43	0.00	2.86	0.57	1.72	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	33.39	11.38	0.84	1.77	1.69	0.25	0.34	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	29.04	9.52	1.18	2.70	1.29	0.35	0.47	0.82
seminal vesicle, adult	10201-103F3	52.38	21.16	4.76	3.17	3.70	4.23	0.53	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	25.51	6.56	1.94	0.73	0.97	3.16	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	19.12	8.05	1.01	1.26	0.75	0.25	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	35.12	5.02	2.01	2.01	0.00	2.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	32.37	9.40	0.94	3.36	1.21	0.81	0.94	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	36.70	6.74	1.88	1.44	1.55	1.22	0.88	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	17.16	6.97	2.71	0.77	0.77	2.45	0.52	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	55.33	19.86	0.71	0.71	0.71	0.71	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	40.90	16.55	1.56	0.60	1.80	0.24	1.08	0.12
skeletal muscle, fetal, donor1	10066-101I3	16.08	12.06	0.00	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	54.28	6.79	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	41.66	18.94	3.79	2.52	0.63	1.26	0.63	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	54.70	9.67	2.00	1.00	1.00	1.33	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	55.16	23.01	0.32	3.78	2.52	0.63	1.89	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	85.58	16.38	2.12	3.47	4.63	2.12	1.35	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	38.90	11.04	4.45	2.14	1.48	5.44	1.81	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	49.54	10.62	0.97	1.29	2.25	1.13	1.13	1.45
small cell lung carcinoma cell line:WA-hT	10562-108A4	27.24	9.15	1.09	1.96	0.22	1.31	1.53	0.00
small intestine, adult, pool1	10024-101D6	64.50	18.63	4.78	1.19	1.55	3.58	0.84	0.60
small intestine, fetal, donor1	10064-101I1	26.04	11.06	1.23	1.97	0.98	0.49	1.47	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	36.42	4.10	0.51	2.56	0.00	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	79.35	13.44	1.03	3.88	2.07	0.78	1.29	0.26
somatostatinoma cell line:QGP-1	10781-110G7	46.90	5.90	1.07	0.27	1.34	0.27	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	47.26	32.12	2.52	2.06	1.84	0.92	2.29	0.92
spinal cord, adult, donor10252	10159-103A6	119.07	38.24	2.37	0.79	4.34	0.79	1.18	0.79
spinal cord, adult, donor10258	10369-105F9	47.04	22.14	0.69	5.53	1.38	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	35.37	18.30	3.05	1.83	1.83	0.61	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	67.50	21.12	3.21	3.21	1.38	0.46	1.38	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	25.24	5.23	2.09	1.05	0.60	0.75	0.60	0.30
spleen, adult, pool1	10025-101D7	45.49	27.31	0.99	1.65	1.10	0.55	0.66	0.44
spleen, fetal, pool1	10044-101F8	54.98	20.02	0.72	0.56	1.11	0.87	1.43	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	24.43	10.87	2.07	1.14	1.14	1.04	0.41	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	33.80	7.03	0.38	0.95	0.76	0.00	0.76	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	31.80	8.74	1.40	4.89	1.75	0.70	0.35	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	22.67	7.04	0.78	0.00	0.39	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	21.84	8.55	0.90	1.35	1.24	0.56	1.46	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	31.77	8.90	2.12	3.81	1.69	0.85	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	22.85	13.96	3.38	0.42	0.85	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	51.26	32.04	5.34	0.00	2.14	2.14	1.07	1.07
submaxillary gland, adult	10202-103F4	38.74	21.08	2.85	0.57	1.71	2.28	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	162.82	108.55	0.00	108.55	54.27	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	101.36	31.57	2.08	6.44	3.74	0.83	1.04	1.45
substantia nigra, adult, donor10258	10371-105G2	51.21	16.55	1.03	2.07	1.55	1.03	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	43.10	9.89	0.71	0.71	0.00	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	50.90	5.04	0.92	2.98	2.06	0.46	1.15	0.92
temporal lobe, adult, pool1	10031-101E4	44.84	18.82	1.19	1.02	2.63	0.51	0.76	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	47.72	16.38	1.42	0.71	2.85	2.85	1.42	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	52.31	16.26	4.83	0.88	1.32	2.20	0.88	0.00
tenocyte, donor1	11763-123H8	24.44	5.93	0.35	4.89	0.70	0.35	1.75	0.00
tenocyte, donor2	11765-123I1	22.89	8.77	0.76	1.14	0.76	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	18.90	4.45	1.48	2.22	1.48	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	48.27	12.92	1.53	2.21	1.36	0.51	1.02	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	47.02	13.10	1.23	3.08	0.77	0.62	2.00	2.00
teratocarcinoma cell line:PA-1	10807-111A6	33.63	9.14	1.39	2.79	1.24	0.46	0.31	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	24.63	9.90	0.89	0.76	1.14	0.89	0.63	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	49.16	16.64	0.00	2.27	3.40	0.76	0.76	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	90.19	21.59	2.07	1.96	2.94	1.53	2.29	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	33.22	6.19	0.98	3.58	1.30	0.65	0.33	0.00
testis, adult, pool1	10026-101D8	67.00	17.29	1.72	2.36	3.54	0.54	1.18	0.86
testis, adult, pool2	10096-102C6	94.28	14.43	2.71	5.41	3.61	2.26	0.00	2.71
thalamus - adult, donor10196	10168-103B6	60.72	23.18	1.10	1.10	6.62	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	123.93	37.04	1.88	4.53	3.91	1.09	1.09	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	32.33	15.40	0.00	0.00	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	16.14	13.67	0.33	2.47	0.82	0.33	1.15	0.49
thalamus, newborn, donor10223	10366-105F6	21.86	9.78	2.88	0.58	1.15	0.00	0.00	0.00
throat, adult	10209-103G2	41.20	25.22	3.00	0.75	1.50	2.00	1.25	0.50
throat, fetal, donor1	10061-101H7	35.04	21.63	1.52	1.52	1.52	0.91	1.22	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	28.22	6.36	0.99	0.99	1.39	0.60	1.39	0.40
thymus, adult, pool1	10027-101D9	69.69	21.67	3.28	2.09	1.29	1.69	1.69	0.50
thymus, fetal, pool1	10043-101F7	100.27	17.87	2.70	1.66	1.66	2.39	1.25	1.35
thyroid carcinoma cell line:KHM-5M	10776-110G2	14.89	4.25	1.06	0.66	0.80	0.53	0.53	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	28.64	9.64	0.56	1.96	1.12	0.56	0.84	0.14
thyroid, adult, pool1	10028-101E1	84.91	27.81	1.87	1.59	2.52	1.03	1.77	0.28
thyroid, fetal, donor1	10060-101H6	44.03	21.36	2.11	1.32	2.64	0.53	2.11	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	107.79	21.56	0.00	0.00	9.24	0.00	0.00	0.00
tongue, adult	10203-103F5	27.91	15.58	3.02	1.40	1.16	0.00	0.47	0.23
tongue, fetal, donor1	10059-101H5	21.68	11.03	3.15	0.79	0.00	0.79	0.00	0.39
tonsil, adult, pool1	10047-101G2	54.20	18.43	2.40	0.60	0.80	0.70	0.90	1.10
trachea, adult, pool1	10029-101E2	46.79	17.01	1.39	0.41	1.39	0.98	0.57	0.33
trachea, fetal, donor1	10058-101H4	38.08	15.77	1.92	0.77	0.77	1.92	1.15	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	12.05	3.90	1.77	0.71	1.06	0.00	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	30.80	9.02	1.42	0.51	1.32	0.81	0.30	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	52.33	9.71	2.19	2.82	3.92	0.94	0.63	0.78
tridermal teratoma cell line:HGRT	10694-109G1	30.44	7.61	1.90	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	25.14	9.23	1.02	0.51	0.59	0.51	0.76	0.25
umbilical cord, fetal, donor1	10057-101H3	18.78	4.17	2.09	0.00	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	95.72	26.62	2.39	0.34	3.07	0.68	2.90	0.85
uterus, fetal, donor1	10055-101H1	35.32	20.48	0.51	2.05	0.00	1.02	3.07	1.02
vagina, adult	10204-103F6	188.04	16.80	2.58	0.00	7.11	1.94	1.29	0.65
vein, adult	10191-103E2	39.02	27.18	1.97	0.88	0.44	1.32	1.10	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	16.56	10.15	0.53	1.60	0.27	0.27	0.80	0.27